Melanocytic naevi of trunk

CD2_BENIGN_MELANOCYTIC_TRUNK

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D22.5& Hospital discharge: ICD-9 — 2165A Cause of death: ICD-10 — D22.5& Cause of death: ICD-9 — 2165A 2 out of 7 registries used, show all original rules.	6047
4. Check minimum number of events None	6047
5. Include endpoints None	6047
6. Filter based on genotype QC (FinnGen only)	5515

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D22
Name in latin: Naevus melanocyticus (cutis) trunci

NAME	CD2_BENIGN_MELANOCYTIC_TRUNK
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D225
HD_ICD_9	2165A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D225
COD_ICD_9	2165A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Melanocytic naevi of trunk based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	29275	16097	13097
Only index persons	27901	15497	12404
Unadjusted period prevalence (%)
Whole population	0.42	0.46	0.37
Only index persons	0.53	0.57	0.47
Median age at first event (years)
Whole population	44.81	41.41	49.03
Only index persons	45.35	41.84	49.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5515	3228	2287
Unadjusted period prevalence (%)	1.11	1.15	1.05
Median age at first event (years)	52.79	46.58	61.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5672: Matched controls
56720

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

96.2

323.0

168

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

7.5

307.7

991

1560

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

9.2

307.7

536

637

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

36.9

307.7

386

112

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

22.2

307.7

2434

1855

L57.0

ICD-10 Finland

Actinic keratosis

4.6

307.7

1068

2738

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

5.2

307.7

1045

2368

XQ848

NOMESCO Finland

Dermatological photography

8.2

307.7

519

692

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

5.5

307.7

895

1877

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

10.6

307.7

449

456

XQ845

NOMESCO Finland

Dermatoscopy

13.7

307.7

486

385

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1081.3

307.7

5484

1490

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

8.7

307.7

1654

2568

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

28.8

298.0

200

D03.5

ICD-10 Finland

Melanoma in situ of trunk

35.8

293.6

184

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

7.4

292.6

440

634

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

21.9

291.5

217

103

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

27.9

290.7

197

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

7.7

287.3

419

583

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

17.5

284.0

234

139

TQW99

NOMESCO Finland

Other minor procedure on skin

5.4

277.6

592

1205

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

4.7

266.6

666

1549

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

7.5

264.9

394

560

R23.8

ICD-10 Finland

Other and unspecified skin changes

2.8

264.1

1815

8103

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

9.5

248.9

302

335

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

8.8

245.4

317

381

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

7.8

235.0

334

450

L82

ICD-10 Finland

Seborrhoeic keratosis

2.8

229.4

1485

6361

2165A

ICD-9 Finland

Benign neoplasm of skin, Skin of trunk, except scrotum[VARTALON IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]

+∞

209.7

200

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

14.2

188.9

173

125

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

7.6

184.7

266

363

127

Kela drug reimbursment

Transplant complication

8.1

175.6

240

308

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

3.8

167.8

563

1614

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

26.2

163.4

113

ZXC50

NOMESCO Finland

Cryotherapy

5.4

161.9

328

632

PJA12

NOMESCO Finland

Sentinel node biopsy

3.3

149.3

619

2030

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

21.1

149.0

112

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.8

133.9

250

446

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

6.3

132.5

226

369

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

25.3

131.4

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

19.4

129.5

101

Z94.0

ICD-10 Finland

Kidney transplant status

8.3

126.4

168

208

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.3

118.7

125

113

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

13.1

117.9

113

C43

ICD-10 Finland

Malignant melanoma of skin

25.2

117.0

D22

ICD-10 Finland

Melanocytic naevi

3.1

116.5

523

1790

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

25.7

116.3

S18

ICPC

Laceration/cut

1.9

116.0

2855

19819

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

4.8

114.6

269

587

S82

ICPC

Naevus/mole

2.3

114.5

1063

5207

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

22.2

112.7

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

6.2

110.1

191

317

9733

FHL

Excision of skin change in operating room or anesthesia

6.9

107.6

168

250

L04AA06

ATC

mycophenolic acid; systemic

5.2

106.4

222

438

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

14.6

105.8

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

7.6

101.2

145

196

ZZR00

NOMESCO Finland

Flap of skin

5.2

98.3

205

404

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

24.9

98.1

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

8.6

96.2

123

145

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

8.2

91.8

122

151

L04AD01

ATC

ciclosporin; systemic

5.0

89.8

196

402

L04AD02

ATC

tacrolimus; systemic

6.9

89.7

139

205

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

5.0

85.6

186

380

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

12.0

84.1

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

5.9

82.5

149

257

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.5

79.6

197

448

Z2221

NOMESCO Finland

Medical doctor

1.8

77.6

1632

10463

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

37.2

77.3

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

24.1

77.2

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

13.5

76.7

137

Kela drug reimbursment

Uraemia requiring dialysis

7.6

75.8

108

145

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

7.6

75.8

108

145

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

3.8

73.9

233

634

ZXC15

NOMESCO Finland

Use of photodynamic technique

6.0

73.1

130

221

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.4

72.8

188

442

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

13.9

71.5

L01BC02

ATC

fluorouracil; systemic, topical

8.5

70.8

108

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

8.8

69.4

100

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

8.3

69.3

111

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

14.8

67.3

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

14.8

67.3

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

8.8

65.9

D06BB10

ATC

imiquimod; topical

2.7

65.8

386

1515

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

7.5

65.6

127

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

3.9

65.6

197

518

A12AA04

ATC

calcium carbonate; oral

5.0

65.5

143

293

ZQZ00

NOMESCO Finland

Treatment of several skin areas

9.9

65.1

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

5.3

64.7

132

255

SPAT1153

SPAT

Removal of sutures

1.7

63.6

1703

11553

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

9.7

62.8

L04AA01

ATC

[U] ciclosporin

5.3

62.6

127

244

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

5.2

60.9

125

243

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

9.0

57.5

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

10.6

56.8

A11CC03

ATC

alfacalcidol; systemic

3.7

55.0

181

507

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

11.9

51.4

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.3

50.8

103

198

TQW40, ,

SPAT

2.0

50.2

629

3379

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

6.1

49.5

143

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

7.9

48.9

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

11.8

48.1

TK800

NOMESCO Finland

Hemodialysis

3.6

47.9

159

448

TQW80

NOMESCO Finland

Local dermatologic skincare

3.1

47.4

198

645

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

47.1

1946

14408

S77

ICPC

Malignant neoplasm of skin

5.2

46.9

190

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

7.1

45.3

ZXC20

NOMESCO Finland

Use of chemical agents

3.9

44.9

132

342

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

5.5

44.8

161

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

5.8

43.5

137

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

3.1

43.0

188

629

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

7.4

42.3

R4110

NOMESCO Finland

Physiotherapy

1.6

42.1

1461

10357

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.1

42.0

178

B05DA

ATC

Isotonic solutions

5.8

41.0

131

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

12.6

40.9

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

40.8

1807

13478

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

14.3

40.8

L91.0

ICD-10 Finland

Hypertrophic scar

4.0

40.7

116

294

B05DB

ATC

Hypertonic solutions

6.1

40.4

116

E0000UV, ,

ATC

1.5

40.3

2291

17942

QBA10

NOMESCO Finland

Incision of skin of trunk

4.5

40.3

220

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.1

39.9

167

180

Kela drug reimbursment

Interferon alfa

10.1

39.8

ZXA05

NOMESCO Finland

Left side

1.6

39.6

1175

8022

Z3231

NOMESCO Finland

Registered nurse

1.5

39.3

1429

10210

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

8.8

39.3

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

8.0

39.2

S29

ICPC

Skin symptom/complaint other

1.6

39.1

1139

7739

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

5.1

38.8

160

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

7.3

38.5

ZXA00

NOMESCO Finland

Right side

1.6

38.3

1257

8773

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

12.8

38.3

L04AX01

ATC

azathioprine; systemic

2.4

37.8

270

1160

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.3

37.4

141

432

Z94.4

ICD-10 Finland

Liver transplant status

8.5

37.3

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

8.0

37.1

S21

ICPC

Skin texture symptom/complaint

1.7

36.0

847

5451

Z49.2

ICD-10 Finland

Other dialysis

5.5

35.7

127

DHB00

NOMESCO Finland

Excision of lesion of external nose

5.1

35.7

149

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

35.3

2393

19212

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

35.1

1341

9643

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

7.0

35.1

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

35.1

140

444

B07.9

ICD-10 Finland

Verruca simplex

2.4

35.1

248

1061

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

8.8

34.5

ZXE00

NOMESCO Finland

One hour or less

1.4

34.3

1998

15587

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.0

34.1

250

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

13.4

33.9

WX402

NOMESCO Finland

General anaesthesia

1.5

33.6

1237

8818

V03AE02

ATC

sevelamer; oral

6.3

33.4

N18.0

ICD-10 Finland

End-stage renal disease

4.7

33.1

167

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

5.3

32.7

123

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

10.3

32.4

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.3

32.2

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

11.9

31.6

D22.0

ICD-10 Finland

Melanocytic naevi of lip

8.1

31.6

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

31.4

302

1468

J01DB01

ATC

cefalexin; oral

1.5

30.7

4549

41426

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.6

30.5

162

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

6.2

30.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

7.1

30.1

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.7

29.1

S52

ICPC

Skin, Exc/remov/biopsy/destruc/debrid/caut

5.7

28.9

Z3226

NOMESCO Finland

Physiotherapist

1.5

28.7

897

6147

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

33.8

28.7

ZXA10

NOMESCO Finland

Bilateral

1.5

28.0

863

5893

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.1

27.7

192

QXA05

NOMESCO Finland

Skin division, unspecified location

6.5

27.7

Z94.1

ICD-10 Finland

Heart transplant status

9.7

27.6

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

27.4

251

1196

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

27.2

317

1651

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

27.1

1144

8333

V03AE01

ATC

polystyrene sulfonate; oral

3.8

27.1

222

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.0

26.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

26.8

706

4650

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

26.7

1507

11573

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

26.4

1008

7195

J01MA02

ATC

ciprofloxacin; systemic

1.4

26.2

1891

15124

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

6.2

26.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

25.9

893

6239

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

7.7

25.9

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

6.4

25.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

25.1

1163

8610

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

25.0

491

3002

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

3.9

24.9

185

B03XA01

ATC

erythropoietin; parenteral

4.5

24.7

135

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

24.6

1390

10652

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

24.6

325

1766

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.8

24.5

359

2015

D22.2

ICD-10 Finland

Melanocytic naevi of ear and external auricular canal

8.7

24.5

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.3

24.5

193

866

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

24.4

1968

15972

Z31.5

ICD-10 Finland

Genetic counselling

1.9

24.2

317

1718

JJC00

NOMESCO Finland

Allogenic transplantation of liver

8.4

24.0

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

4.9

23.8

107

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

33.5

23.3

L03AB05

ATC

interferon alfa-2b; parenteral

7.0

23.3

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

5.0

23.2

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

8.4

23.1

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.1

23.1

212

1012

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

6.5

23.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

22.8

2014

16523

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

22.4

122

461

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

5.7

22.4

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.2

22.2

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.7

22.1

110

ZZA00

NOMESCO Finland

Split skin graft

2.5

22.0

140

571

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

21.9

278

1490

TK820

NOMESCO Finland

Peritoneal dialysis

5.3

21.8

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

21.7

1111

8343

A98

ICPC

Health maint/preventive medicine

2.1

21.5

5495

53116

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

21.4

226

1138

ZX120

NOMESCO Finland

Intravenous

1.7

21.4

449

2791

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

7.5

21.2

UJF32

NOMESCO Finland

Coloscopy

1.4

21.1

1205

9214

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

33.9

21.1

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

5.8

21.0

UKC02

NOMESCO Finland

Cystoscopy

1.5

20.8

719

5012

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

20.7

172

790

DAB00

NOMESCO Finland

Excision of lesion of auricle

3.7

20.5

174

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2.6

20.4

122

484

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

20.3

613

4152

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

5.4

20.2

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

20.2

1058

7967

D06BX02

ATC

ingenol mebutate; topical

3.5

20.1

195

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.1

20.1

270

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

18.8

19.9

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

18.8

19.9

N02BE01

ATC

paracetamol; systemic, rectal

1.4

19.6

4828

45382

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

16.4

19.6

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

7.7

19.5

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

17.7

19.5

WX002

NOMESCO Finland

Sedation and analgesia

1.4

19.4

867

6343

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

4.7

19.3

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

19.3

3903

35533

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

19.2

303

1740

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

16.8

19.1

ZXD20

NOMESCO Finland

Day surgery

1.5

19.1

595

4055

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

7.5

19.1

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

2.3

19.0

147

656

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

3.4

18.8

194

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

2.1

18.7

169

803

DAB10

NOMESCO Finland

Partial excision of auricle

5.3

18.7

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

5.9

18.7

J01FA10

ATC

azithromycin; systemic

1.3

18.7

3015

26594

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.1

18.6

180

878

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

18.5

614

4237

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.0

18.5

214

1114

HA1AA

NOMESCO Finland

X-ray mammography

1.7

18.4

353

2140

QBE10, ,

SPAT

3.1

18.3

248

C43.42

ICD-10 Finland

Malignant melanoma of the scalp and neck: 'superficial spreading' type

17.6

18.2

K07.60

ICD-10 Finland

Snapping jaw

1.8

18.1

285

1636

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

18.1

292

1689

H02AB04

ATC

methylprednisolone; systemic

1.5

17.9

657

4629

QBE99, ,

SPAT

3.5

17.8

172

9734

FHL

Excision and local plastic or associated free skin grafting

4.4

17.7

101

L01XE23

ATC

[U] dabrafenib

22.8

17.7

D07AC01

ATC

betamethasone; topical

1.3

17.6

1797

14912

V03AE03

ATC

lanthanum carbonate; oral

5.1

17.4

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.1

17.4

174

860

J01CA04

ATC

amoxicillin; systemic

1.3

17.3

4445

41425

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.4

17.3

118

498

XKD00

NOMESCO Finland

Uroflowmetry

1.5

17.0

681

4874

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

16.8

1535

12536

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

12.7

16.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

16.5

646

4602

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

16.5

402

2589

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.3

16.5

C43.49

ICD-10 Finland

Malignant melanoma of the scalp and neck other or unspecified histology

27.6

16.5

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.2

16.3

133

607

F16

ICPC

Eyelid symptom/complaint

1.8

16.3

268

1558

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.1

16.3

159

779

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

16.2

329

2025

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.0

16.2

164

815

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

16.1

131

598

A02BC02

ATC

pantoprazole; systemic

1.3

16.0

3457

31311

TQB05

NOMESCO Finland

Puncture of skin of trunk

3.2

15.9

190

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.7

15.9

331

D07AD01

ATC

clobetasol; topical

1.4

15.9

788

5858

J05AB11

ATC

valaciclovir; oral

1.4

15.9

706

5149

3AC01, ,

NOMESCO Finland

3.2

15.8

186

5AB14, ,

NOMESCO Finland

12.2

15.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

15.8

454

3037

Z71.8

ICD-10 Finland

Other specified counselling

1.3

15.8

1779

14902

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

15.6

1862

15704

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

6.0

15.6

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

5.6

15.5

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.5

15.5

365

WW200

NOMESCO Finland

Immunization

2.1

15.3

142

683

J05AB01

ATC

aciclovir; systemic

1.3

15.2

1051

8231

8742/3-C44.9

ICD-O-3

Lentigo maligna melanoma of skin, NOS

28.7

15.2

JN4BD

NOMESCO Finland

Extensive body CT

1.5

15.2

439

2941

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

4.1

15.1

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

14.9

213

1188

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

3.3

14.9

168

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

14.8

334

2113

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.6

14.8

309

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

5.0

14.8

H05BX01

ATC

cinacalcet; oral

4.0

14.7

103

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.6

14.6

131

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

14.6

548

3872

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.0

14.6

104

A02BC01

ATC

omeprazole; systemic

1.3

14.5

1219

9806

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

14.4

1427

11730

J01AA02

ATC

doxycycline; systemic

1.3

14.4

3941

36437

D01AE16

ATC

amorolfine; topical

1.5

14.4

498

3461

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

14.4

109

483

D03.9

ICD-10 Finland

Melanoma in situ, unspecified

15.4

14.4

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

14.3

179

957

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

14.1

530

3742

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

2.7

14.1

265

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

14.1

170

899

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

14.0

561

4012

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

14.0

847

6498

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.4

13.9

561

4016

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

15.8

13.9

J02AC01

ATC

fluconazole; systemic

1.3

13.8

1927

16493

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

5.1

13.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

13.6

158

825

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

4.8

13.5

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.4

13.4

391

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

12.8

13.4

ZX197, ,

NOMESCO Finland

18.2

13.3

Z01.7

ICD-10 Finland

Laboratory examination

1.4

13.3

819

6293

Z2446

NOMESCO Finland

Social worker

1.6

13.1

301

1911

A02BC05

ATC

esomeprazole; systemic

1.2

13.1

1906

16368

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.5

13.0

306

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

13.0

775

5927

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

13.0

892

6967

R31

ICD-10 Finland

Unspecified haematuria

1.5

12.9

436

3016

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.7

12.9

109

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

12.9

1704

14472

205

Kela drug reimbursment

Chronic hypertension

1.3

12.8

983

7795

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

4.7

12.8

R01AD09

ATC

mometasone; nasal

1.2

12.6

2304

20252

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

12.5

345

2286

7151

FHL

Kidney transplantation

13.2

12.4

JJ5AT, ,

NOMESCO Finland

13.2

12.4

C08CA02

ATC

felodipine; oral

1.5

12.3

356

2384

XF404

NOMESCO Finland

Ambulatory ECG

1.5

12.3

363

2442

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

12.2

474

3366

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.1

12.2

163

D18.0

ICD-10 Finland

Haemangioma, any site

2.0

12.2

126

632

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

15.9

12.1

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

12.1

360

2426

S15

ICPC

Foreign body in skin

1.6

12.1

297

1919

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

2.4

12.1

360

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

12.0

503

3622

ZX108

NOMESCO Finland

Inhalation

3.4

12.0

129

D23

ICD-10 Finland

Other benign neoplasms of skin

2.0

11.9

121

603

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.1

11.9

105

496

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

3.2

11.9

145

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

11.8

394

2719

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

10.5

11.7

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

10.5

11.7

ZZA50

NOMESCO Finland

Full thickness skin graft

3.9

11.7

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

9.6

11.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

11.7

207

1231

S59

ICPC

Skin, Other therap proced/minor surg NEC

2.0

11.7

115

567

3016

Kela drug reimbursment

Binimetinib and encorafenib

30.1

11.6

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

18.9

11.6

L01XE25

ATC

[U] trametinib

22.9

11.6

R42

ICD-10 Finland

Dizziness and giddiness

1.3

11.5

1008

8126

C44

ICD-10 Finland

Other malignant neoplasms of skin

5.2

11.5

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.8

11.5

164

916

H02AB09

ATC

hydrocortisone; systemic

2.0

11.4

119

599

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.5

11.4

283

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.1

11.4

106

512

S26

ICPC

Fear of cancer of skin

2.7

11.4

231

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.3

11.3

370

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

11.3

342

2313

D07XC01

ATC

betamethasone; topical

1.4

11.3

527

3870

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

11.3

476

3435

TQW20

NOMESCO Finland

Tatoe

2.7

11.1

205

L01EC02

ATC

dabrafenib; oral

12.7

11.1

D03.4

ICD-10 Finland

Melanoma in situ of scalp and neck

20.1

11.1

B01AB05

ATC

enoxaparin; parenteral

1.3

11.1

1379

11593

D10BA01

ATC

isotretinoin; oral

1.5

11.0

324

2178

C08CA01

ATC

amlodipine; oral

1.2

11.0

1593

13621

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

10.9

357

2454

C43.82

ICD-10 Finland

Overall malignant melanoma of the skin: 'superficial spreading' type

43.4

10.9

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

10.9

433

3091

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

10.8

521

3844

C43.40

ICD-10 Finland

Malignant melanoma of the scalp and neck without histology

15.5

10.8

JN4AD

NOMESCO Finland

Body CT examination

1.4

10.8

482

3511

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

3.0

10.8

159

D02AE01

ATC

carbamide; topical

1.6

10.8

281

1841

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

9.6

10.7

B35.1

ICD-10 Finland

Tinea unguium

1.5

10.7

314

2110

1513

Kela drug reimbursment

Binimetinib and encorafenib

28.1

10.7

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

4.4

10.7

QXE15

NOMESCO Finland

Excision of other superficial lesion of skin in unspecified region

21.5

10.7

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.6

10.6

L01BB01, ,

ATC

8.0

10.6

N64.9

ICD-10 Finland

Disorder of breast, unspecified

2.6

10.5

217

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

10.5

2638

23787

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

2.4

10.4

296

XF612

NOMESCO Finland

Measurement of central venous pressure

5.4

10.4

R50.9

ICD-10 Finland

Fever, unspecified

1.3

10.3

708

5518

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

3.5

10.3

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

10.6

10.3

130

Kela drug reimbursment

Malignant tumour

1.5

10.2

352

2444

ZXB10

NOMESCO Finland

Medial

3.3

10.2

112

D02AX

ATC

Other emollients and protectives

1.8

10.2

140

774

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

10.2

220

1379

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

10.2

1032

8463

C03CA01

ATC

furosemide; systemic

1.3

10.1

1100

9094

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

2.0

10.1

103

516

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

4.8

10.0

C07AG02

ATC

carvedilol; oral

1.6

10.0

211

1316

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

14.6

10.0

BE00A, ,

NOMESCO Finland

40.1

10.0

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

4.0

9.9

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

9.9

249

1618

C02CA01

ATC

prazosin; oral

2.6

9.9

224

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.6

9.9

XF602

NOMESCO Finland

Bloodpressure monitoring

2.5

9.9

236

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.1

9.8

413

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

5.1

9.8

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.5

9.8

243

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.6

9.8

238

1535

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

9.8

2697

24460

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

9.8

114

598

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

4.9

9.8

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

9.7

331

2294

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.8

9.7

142

801

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

2.9

9.6

148

115

Kela drug reimbursment

Breast cancer

1.5

9.6

309

2119

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

11.4

9.5

SAA04

NOMESCO Finland

Special examination of mouth

1.6

9.5

236

1530

4056, ,

NOMESCO Finland

10.0

9.5

C02AC05

ATC

moxonidine; oral

1.7

9.5

179

1085

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

9.5

406

2937

J01FF01

ATC

clindamycin; systemic

1.2

9.4

1225

10321

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

9.4

336

2350

R23

ICD-10 Finland

Other skin changes

2.4

9.4

254

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

5.1

9.3

QBA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of trunk

12.3

9.3

8743/3-C44.7

ICD-O-3

Low cumulative sun damage melanoma of skin of lower limb and hip

21.7

9.3

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

9.3

1802

15801

602

Kela drug reimbursment

Children's severe malnutrition

4.9

9.3

D07AB08

ATC

desonide; topical

1.4

9.3

481

3593

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

2.4

9.3

244

N02AX02

ATC

tramadol; systemic, rectal

1.2

9.2

1956

17294

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

9.2

278

1881

G04CA02

ATC

tamsulosin; oral

1.3

9.2

930

7618

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

9.2

201

1266

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

2.7

9.2

169

H02AB06

ATC

prednisolone; systemic

1.2

9.2

2239

20051

WZC15, ,

NOMESCO Finland

2.8

9.1

164

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.8

9.1

153

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.2

9.1

354

S97

ICPC

Chronic ulcer skin

1.5

9.1

241

1588

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

11.5

9.0

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.2

9.0

309

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

8.3

9.0

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

9.0

129

723

HA1RA, ,

SPAT

1.6

9.0

200

1263

TK810

NOMESCO Finland

Hemofiltration

3.3

9.0

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.3

9.0

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

9.0

388

2811

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

9.0

403

2939

SDA03

NOMESCO Finland

Periodontal treatment

1.2

9.0

2062

18356

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

8.9

1186

10011

5602

FHL

Internal fistula (eg Cimino)

24.0

8.9

TQX10, ,

SPAT

4.3

8.9

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

8.8

126

2164

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

1.9

8.8

109

584

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

8.8

421

3103

QAE99, ,

SPAT

2.6

8.8

190

L01EE01

ATC

trametinib; oral

10.7

8.8

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

2.0

8.8

439

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

8.7

2638

24024

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

8.7

218

1416

ZXC12

NOMESCO Finland

Pulse colorlaser

4.1

8.7

H02.3

ICD-10 Finland

Blepharochalasis

1.5

8.7

248

1659

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

8.7

361

2599

A12AA12

ATC

[U] calcium acetate

8.2

8.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

8.5

261

1773

D10AX03

ATC

azelaic acid; topical

1.4

8.5

344

2465

L84

ICD-10 Finland

Corns and callosities

1.7

8.4

146

866

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1.9

8.4

501

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

3.7

8.4

S08

ICPC

Skin colour change

1.5

8.4

233

1549

J02AC02

ATC

itraconazole; systemic

1.3

8.4

754

6084

I78.10

ICD-10 Finland

Senile angioma

3.6

8.4

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.3

8.4

281

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.9

8.4

127

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

8.4

1112

9381

D48

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other and unspecified sites

4.5

8.4

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

8.4

187

1185

D05BB02

ATC

acitretin; oral

1.9

8.3

503

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

8.3

594

4653

Z99.2

ICD-10 Finland

Dependence on renal dialysis

8.5

8.3

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

8.2

157

956

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

8.2

515

3960

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

8.2

462

3496

N63

ICD-10 Finland

Unspecified lump in breast

1.4

8.2

298

2094

8720/3-C44.4

ICD-O-3

Malignant melanoma, NOS, of skin of scalp and neck

14.5

8.2

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.6

8.1

177

1114

L21

ICD-10 Finland

Seborrhoeic dermatitis

2.0

8.1

424

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

8.1

555

4319

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.9

8.1

101

543

R4120

NOMESCO Finland

Occupational therapy

1.5

8.1

282

1964

D01BA02

ATC

terbinafine; oral

1.2

8.1

1110

9387

J01MA06

ATC

norfloxacin; oral

1.3

8.1

502

3852

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

8.1

295

2073

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

2.3

8.1

266

XQ800

NOMESCO Finland

Prick test

1.4

8.1

334

2402

C08CA13

ATC

lercanidipine; oral

1.3

8.1

549

4269

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

1.9

8.1

530

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

2.6

8.1

175

H3603, E103,

ICD-10 Finland

2.5

8.0

187

WXQ99

NOMESCO Finland

Other light therapy

8.9

8.0

C43.33

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face nodular

22.0

8.0

WX704

NOMESCO Finland

Intubation

1.4

8.0

354

2577

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

3.6

8.0

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.5

8.0

221

1471

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

8.0

377

2776

UJH02

NOMESCO Finland

Anoscopy

1.6

7.9

162

1004

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3.4

7.9

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.4

7.9

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.2

7.9

288

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.0

7.9

381

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.7

7.9

134

792

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1.6

7.9

157

968

B02AA02

ATC

tranexamic acid; systemic

1.3

7.8

652

5212

L04AA05

ATC

[U] tacrolimus

8.4

7.8

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

7.8

149

909

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

6.9

7.8

Z01.2

ICD-10 Finland

Dental examination

1.2

7.7

2364

21476

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

7.7

1415

12307

C43.22

ICD-10 Finland

Malignant melanoma of outer ear and outer ear canal: 'superficial spreading' type

45.0

7.7

6119

FHL

Other measure in this category

45.0

7.7

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

7.7

388

2887

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

7.7

415

3121

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

4.3

7.7

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.8

7.7

105

583

A97

ICPC

No disease

1.2

7.6

922

7693

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

7.6

597

4734

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

4.0

7.6

I51.1

ICD-10 Finland

Rupture of chordae tendineae, not elsewhere classified

18.4

7.6

8720/2-C44.5

ICD-O-3

Melanoma in situ of skin of trunk

18.4

7.6

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

7.6

214

1431

QAA25, ,

SPAT

3.1

7.5

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

8.8

7.5

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

1.5

7.5

229

1555

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

6.1

7.5

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

7.5

1328

11510

L02BA01

ATC

tamoxifen; oral

1.6

7.5

151

934

C09CA06

ATC

candesartan; oral

1.2

7.5

1048

8879

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.3

7.5

231

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.7

7.5

121

706

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.5

7.5

225

1525

L85.3

ICD-10 Finland

Xerosis cutis

2.3

7.4

219

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

4.4

7.4

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

1.9

7.4

425

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

7.4

855

7098

C08CA05

ATC

nifedipine; systemic

1.5

7.4

212

1422

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

2.3

7.4

226

BAA60

NOMESCO Finland

Total thyroidectomy

1.8

7.4

106

598

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1.5

7.3

198

1313

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.7

7.3

138

840

8742/3-C44.5

ICD-O-3

Lentigo maligna melanoma of skin of trunk

+∞

7.3

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

10.9

7.3

C03DA01

ATC

spironolactone; oral

1.3

7.3

459

3533

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

7.3

662

5347

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.5

7.3

231

1583

-, ,

ICD-10 Finland

1.9

7.3

456

D23.4

ICD-10 Finland

Benign neoplasm: Skin of scalp and neck

2.1

7.3

292

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.4

7.3

281

1999

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.0

7.2

339

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

7.2

246

1708

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

3.2

7.2

C43.29

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology

15.7

7.2

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

7.2

2023

18221

R51.80

ICD-10 Finland

Headache

1.3

7.2

740

6062

L21.0

ICD-10 Finland

Seborrhoea capitis

2.3

7.2

216

E000001, ,

ATC

1.2

7.2

873

7285

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

7.2

508

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

4.5

7.2

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

7.2

385

2894

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.3

7.2

223

C43.89

ICD-10 Finland

Overall malignant melanoma of the skin other or unspecified histology

30.0

7.1

R01AD12

ATC

fluticasone furoate; nasal

1.2

7.1

1551

13678

L01EE03

ATC

binimetinib; oral

20.0

7.1

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

7.1

385

2897

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

1.7

7.1

135

823

J01EA01

ATC

trimethoprim; systemic

1.2

7.1

1082

9239

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.1

1859

16648

D06BX01

ATC

metronidazole; topical

1.3

7.1

454

3503

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

4.1

7.1

L01AA01

ATC

cyclophosphamide; systemic

3.8

7.1

ZX114

NOMESCO Finland

Intramuscular

2.1

7.0

296

H26.4

ICD-10 Finland

After-cataract

1.4

7.0

330

2429

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

7.0

597

4784

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

2.8

6.9

113

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

2.7

6.8

125

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

2.1

6.8

306

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

6.8

953

8067

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

3.8

6.8

EB1WA, ,

NOMESCO Finland

2.8

6.8

120

D03.30

ICD-10 Finland

Melanoma in situ on the lip

40.1

6.8

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

6.7

1277

11122

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

3.1

6.7

3A064, ,

NOMESCO Finland

3.9

6.7

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

7.2

6.7

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

6.7

300

2192

C44.82

ICD-10 Finland

Overall spinocellular carcinoma of the skin

22.5

6.7

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.2

6.7

256

K00.40

ICD-10 Finland

Postnatal enamel hypoplasia

2.5

6.7

156

N07BB01

ATC

disulfiram; oral

0.5

6.7

1149

WGA11

NOMESCO Finland

Planning of pain management

2.9

6.6

105

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.6

6.6

127

2018

XF402

NOMESCO Finland

ECG with work load test

1.3

6.6

388

2958

L02BG04

ATC

letrozole; oral

1.4

6.6

278

2010

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

6.6

218

1508

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

2.7

6.6

128

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.1

6.5

258

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

6.5

164

1070

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

8.7

6.5

5828A

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]

8.7

6.5

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

6.5

1200

10420

GD1LA

NOMESCO Finland

2.1

6.5

272

RD210, ,

NOMESCO Finland

1.9

6.5

424

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

6.5

390

2984

WX320

NOMESCO Finland

Spinalanesthesy

1.2

6.5

1042

8939

ZX090

NOMESCO Finland

Other technic of radiotherapy

1.7

6.4

100

578

ECA35

NOMESCO Finland

Complicated excision of lesion of gingiva

3.9

6.4

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

2.6

6.4

141

M10.3

ICD-10 Finland

Gout due to impairment of renal function

3.4

6.4

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

6.4

278

2020

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.5

6.4

170

1124

HAB40

NOMESCO Finland

Wedge excision of mammary gland

1.5

6.4

169

1116

187

Kela drug reimbursment

MPA

14.3

6.4

K65.0

ICD-10 Finland

Acute peritonitis

2.3

6.4

190

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

6.4

896

7585

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

6.4

180

1206

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

2.8

6.4

113

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.3

6.4

203

L90.6

ICD-10 Finland

Striae atrophicae

3.7

6.4

ZXD05

NOMESCO Finland

Urgent procedure

1.2

6.3

1351

11875

R06AX27

ATC

desloratadine; oral

1.2

6.3

1393

12276

KAC00

NOMESCO Finland

Nephrectomy

4.1

6.3

D10AF01

ATC

clindamycin; topical

1.5

6.3

191

1297

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

6.3

852

7181

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

6.3

1714

15360

C02EA02, ,

ATC

1.6

6.3

126

779

R35

ICD-10 Finland

Polyuria

1.4

6.3

272

1974

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.3

6.3

185

QAE15

NOMESCO Finland

Excision of other superficial lesion of skin from head and neck

5.5

6.3

G03DB01

ATC

dydrogesterone; oral

1.3

6.3

513

4089

N19

ICD-10 Finland

Unspecified kidney failure

1.6

6.3

128

796

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.4

6.3

233

1648

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

18.0

6.3

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

18.0

6.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

2.9

6.3

R39.1

ICD-10 Finland

Other difficulties with micturition

1.6

6.2

123

759

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

1.8

6.2

430

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

2.1

6.2

257

R03BA08

ATC

ciclesonide; inhalant

1.3

6.2

360

2741

C02DE10, ,

ATC

2.5

6.2

150

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

6.3

6.1

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

3.2

6.1

E87.5

ICD-10 Finland

Hyperkalaemia

1.9

6.1

354

AA1AD

NOMESCO Finland

CT of head and brain

1.2

6.1

1172

10206

J01FA06

ATC

roxithromycin; oral

1.2

6.1

1754

15779

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

7.7

6.1

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.5

6.1

186

1266

H25.0

ICD-10 Finland

Senile incipient cataract

1.4

6.1

228

1614

R4190

NOMESCO Finland

Nutritional therapy

1.5

6.1

168

1120

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

6.1

691

5722

H61.2

ICD-10 Finland

Impacted cerumen

1.4

6.1

281

2064

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.5

6.1

198

1366

L04AA10

ATC

[U] sirolimus

12.5

6.1

N05AX08

ATC

risperidone; systemic

0.7

6.0

157

2334

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

1.7

6.0

567

RS220, ,

NOMESCO Finland

2.1

6.0

267

R05

ICD-10 Finland

Cough

1.2

6.0

953

8157

8094/3-C44.9

ICD-O-3

Basosquamous carcinoma of skin, NOS

10.0

6.0

RJ514, ,

NOMESCO Finland

10.0

6.0

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

6.7

6.0

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.6

6.0

134

852

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

1830

6712

3.55

307.65

1.9

1.3

—

(40768804) Tissue Pathology biopsy report

3630

20308

3.19

307.65

3.4

2.1

—

(40768443) Skin Pathology biopsy report

607

2187

2.99

123.80

1.3

1.2

—

(4035726) Immunohistochemistry procedure

904

4179

2.38

111.10

1.6

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

159

218

7.48

109.66

31.3

27.6

98.80

112.93

ug/l

1.76

133

176

(3026250) Tacrolimus [Mass/volume] in Blood

157

233

6.90

100.76

41.7

39.1

6.86

7.42

ug/l

2.32

135

209

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

953

5666

1.82

55.94

6.2

4.5

238.76

240.34

u/l

0.08

918

5385

(3001604) Monocytes [#/volume] in Blood

3244

26201

1.56

55.56

9.1

6.5

0.56

0.58

e9/l

0.40

2848

22650

(3024561) Albumin [Mass/volume] in Serum or Plasma

2781

21763

1.55

54.53

7.4

5.2

36.58

36.01

g/l

7.48

2675

20503

(3006315) Basophils [#/volume] in Blood

3244

26261

1.55

54.51

9.2

6.5

0.04

e9/l

1.90

2852

22699

(3019198) Lymphocytes [#/volume] in Blood

3299

26829

1.55

54.10

9.1

6.5

1.92

1.93

e9/l

0.18

2969

23785

(3013650) Neutrophils [#/volume] in Blood by Automated count

3533

29198

1.56

53.67

12.5

9.7

3.90

4.11

e9/l

7.85

3132

25383

(3013115) Eosinophils [#/volume] in Blood

3306

27092

1.53

50.80

9.4

6.7

0.18

0.19

e9/l

2.06

2956

23813

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

286

1111

2.66

49.61

9.0

5.8

1124.65

2149.29

iu/ml

0.29

146

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4697

41939

1.70

47.83

24.8

18.5

13.52

13.53

0.16

4650

41395

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4287

37763

1.55

42.46

11.4

8.2

75.27

77.79

u/l

3.53

4138

36018

(3002030) Lymphocytes/Leukocytes in Blood

3018

24771

1.47

42.38

9.3

6.6

28.50

28.14

1.07

2908

23547

(3019069) Monocytes/Leukocytes in Blood

2948

24111

1.46

42.00

9.5

6.7

8.74

8.73

0.10

2830

22692

(3022096) Basophils/Leukocytes in Blood

2940

24043

1.46

41.85

9.5

6.7

0.69

0.68

0.71

2816

22576

(3006504) Eosinophils/Leukocytes in Blood

2938

24063

1.46

41.23

9.4

6.6

2.82

2.83

0.09

2818

22615

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

630

3605

1.84

41.02

7.1

4.0

107.64

88.71

ng/l

3.80

574

3156

(3018010) Neutrophils/Leukocytes in Blood

2966

24355

1.46

40.94

9.1

6.5

57.02

57.12

0.18

2880

23319

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

175

5.03

40.80

3.1

2.7

0.61

mmol/l

0.27

175

(3030467) Casts [#/volume] in Urine by Automated count

1859

13994

1.49

39.92

4.6

3.3

0.30

0.39

e6/l

0.99

1398

10240

(3021589) Normoblasts [#/volume] in Blood

2795

22799

1.45

39.31

14.3

11.2

0.00

e9/l

1.33

2281

18625

(3002582) Erythrocytes [#/volume] in Urine

2098

16216

1.47

39.23

4.8

3.4

38.26

90.37

e6/l

3.55

1638

12356

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

227

885

2.63

39.06

5.0

3.0

5145.00

1228.96

u/ml

0.39

(3018095) Leukocytes [#/volume] in Urine

2377

18848

1.45

38.70

5.7

3.9

49.82

87.68

e6/l

1.61

1736

13153

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3111

25936

1.44

38.58

8.7

6.6

11.15

11.30

umol/l

0.25

2989

24757

(3033658) Prothrombin time (PT) actual/Normal

1716

12783

1.49

38.50

5.3

4.1

91.21

90.92

0.18

1687

12510

(3018418) pH of Serum or Plasma

1906

14536

1.47

37.83

7.2

4.3

7.40

0.36

1397

10417

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1247

8711

1.55

37.77

3.7

2.9

1.22

1.03

e6/l

0.20

702

4579

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1159

7981

1.57

37.36

3.9

3.1

1.94

2.58

e6/l

2.38

615

3835

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2926

24305

1.42

35.87

11.2

7.3

1.21

mmol/l

1.33

2613

21109

(3019420) Tryptase [Mass/volume] in Serum or Plasma

112

313

3.63

34.24

1.5

7.79

8.38

ug/l

0.10

107

278

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

322

1561

2.13

33.70

8.0

3.7

1.71

1.48

mg/l

4.48

310

1445

(3003458) Phosphate [Moles/volume] in Serum or Plasma

967

6528

1.58

33.58

12.7

6.3

1.06

1.04

mmol/l

1.08

917

6113

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2634

21667

1.40

33.07

9.7

6.6

1.21

mmol/l

0.80

2491

20163

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2766

22968

1.40

32.73

2.9

2.5

78.78

76.03

nmol/l

6.39

2580

21130

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4151

37032

1.45

32.21

5.2

4.3

10.49

11.16

mm/h

2.76

3937

34937

(3044889) 12 lead EKG panel

3844

33835

1.42

31.96

4.5

3.9

0.20

6540.62

—

(3000850) Epithelial cells [#/volume] in Urine

1497

11225

1.45

31.15

3.9

2.7

3.92

5.88

e6/l

8.61

1381

10216

(3020779) Urea [Moles/volume] in Serum or Plasma

705

4485

1.65

31.07

16.2

7.9

10.61

9.49

mmol/l

3.61

683

4311

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5431

51762

2.16

30.62

15.5

11.7

25.56

26.47

u/l

2.70

5339

50463

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5225

49184

1.79

30.38

19.8

15.2

22.22

23.24

mg/l

1.46

4319

40419

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4951

46051

1.59

28.97

6.2

5.4

1.83

1.86

mu/l

0.61

4733

43125

(40768446) Kidney Pathology biopsy report

204

4.01

28.75

2.0

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

3185

27405

1.37

28.60

4.7

3.8

0.02

0.07

estimate

0.41

634

5475

(3021601) Nitrite [Presence] in Urine by Test strip

3138

26960

1.37

28.31

4.7

3.7

0.00

estimate

0.22

663

5716

(3042733) HLA Ab [Presence] in Serum

168

4.33

28.28

5.4

4.8

—

(3026782) Osmolality of Urine

1290

9559

1.45

28.10

4.2

2.9

509.43

535.14

mosm/kgh2o

0.36

1155

8395

(3035941) MCH [Entitic mass]

5562

53702

2.84

27.88

29.9

23.0

30.26

30.28

0.39

5537

53231

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5562

53703

2.84

27.86

30.0

23.1

90.79

90.83

0.25

5537

53233

(3007461) Platelets [#/volume] in Blood

5561

53693

2.82

27.77

30.1

23.2

251.72

253.65

e9/l

1.44

5496

52768

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5562

53708

2.84

27.76

30.7

23.6

40.44

41.03

2.10

5536

53212

(3026361) Erythrocytes [#/volume] in Blood

5562

53708

2.84

27.76

30.0

23.1

4.51

e12/l

0.19

5484

52652

(3010813) Leukocytes [#/volume] in Blood

5562

53717

2.83

27.58

30.1

23.2

6.60

6.74

e9/l

4.73

5481

52649

(3000963) Hemoglobin [Mass/volume] in Blood

5562

53718

2.83

27.56

30.2

23.3

135.17

135.61

g/l

1.57

5538

53256

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1143

8304

1.47

27.52

5.8

3.6

0.82

mmol/l

0.14

1083

7861

(3015377) Calcium [Moles/volume] in Serum or Plasma

2080

16817

1.37

27.22

5.0

3.4

2.35

mmol/l

0.35

1928

15439

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5431

51954

2.07

27.19

25.1

19.2

81.22

76.01

umol/l

13.38

5399

51400

(3035350) Ketones [Presence] in Urine by Test strip

3153

27239

1.35

26.72

4.7

3.8

8.60

4.27

estimate

0.48

676

5796

(3031040) Bacteria [#/volume] in Urine by Automated count

3719

33005

1.37

26.24

5.3

4.5

450.19

1344.95

e6/l

1.33

429

(3015736) pH of Urine

2584

21726

1.35

25.83

4.1

3.3

6.25

6.22

0.81

1395

12369

(3017143) Hepatitis C virus Ab [Presence] in Serum

967

6881

1.49

25.65

2.1

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2154

17636

1.36

25.55

4.2

3.3

29.00

34.41

u/l

4.00

2059

16730

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4585

42231

1.45

25.39

25.1

19.2

332.60

332.64

g/l

0.11

4572

42005

(3014051) Protein [Presence] in Urine by Test strip

1854

14844

1.37

25.31

3.4

2.8

0.06

0.04

0.13

286

(3014576) Chloride [Moles/volume] in Serum or Plasma

941

6677

1.49

25.28

7.9

7.5

104.60

104.49

mmol/l

0.29

941

6672

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4311

39416

1.39

23.69

5.1

4.4

14.67

14.64

pmol/l

0.37

4066

36599

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1084

8003

1.44

23.53

4.0

2.6

2.29

2.35

g/l

2.73

1018

7429

(3019550) Sodium [Moles/volume] in Serum or Plasma

5194

49273

1.64

23.34

22.5

17.4

139.74

139.67

mmol/l

1.52

5131

48350

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4994

46958

1.53

23.24

19.0

14.5

82.49

84.64

ml/min/173m2

9.95

4653

43233

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1315

10067

1.40

23.21

2.0

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1223

9252

1.41

23.12

4.4

3.7

295.44

545.45

ng/l

1.17

911

6797

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1006

7349

1.45

23.07

4.1

2.7

23.45

23.09

0.38

955

6863

(3023103) Potassium [Moles/volume] in Serum or Plasma

5201

49383

1.64

22.95

23.0

17.5

3.95

3.96

mmol/l

2.26

5134

48350

(44806420) Estimation of glomerular filtration rate

149

615

2.46

22.86

2.5

2.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

853

6060

1.48

22.56

2.1

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

683

4636

1.54

22.47

1.6

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1149

8640

1.41

22.39

4.0

2.6

13.61

13.47

umol/l

0.28

1096

8108

(40760892) CBC W Ordered Manual Differential panel - Blood

1535

12117

1.37

22.31

6.0

4.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1223

9315

1.40

22.08

3.7

2.9

2.44

mmol/l

0.13

1117

8351

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

215

1051

2.09

22.03

1.9

1.4

148.66

151.16

au/ml

0.10

303

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2988

26020

1.31

21.88

4.0

3.2

110.96

111.66

ug/l

0.07

2855

24563

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2792

24101

1.31

21.73

3.1

2.8

—

estimate

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1829

14879

1.34

21.68

2.4

2.2

169.40

215.80

u/l

2.07

1742

14160

(3000991) Gas panel - Venous blood

635

4275

1.55

21.65

10.9

9.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

229

1158

2.02

21.41

2.0

1.4

—

(3000494) Fungus identified in Specimen by Culture

875

6308

1.46

21.37

1.7

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5102

48357

1.55

21.12

5.6

4.9

4.59

4.64

mmol/l

3.59

4892

45780

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3775

34041

1.33

21.08

3.4

3.3

—

(3012544) pH of Venous blood

714

4970

1.50

20.77

6.0

4.0

7.37

7.38

3.29

425

2840

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5149

48929

1.57

20.76

6.2

5.5

2.68

2.73

mmol/l

4.32

4912

46130

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5075

48123

1.52

20.11

5.5

4.8

1.48

1.46

mmol/l

3.15

4835

45302

(40758558) Short blood count panel - Blood

1859

15289

1.32

20.04

8.6

6.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1627

13137

1.33

19.92

3.8

2.7

341.97

336.49

umol/l

1.40

1501

11740

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

4.81

19.84

1.1

2.1

1.47

1.88

ug/l

0.67

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

225

1164

1.97

19.74

1.9

1.4

22.30

19.66

u/ml

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

697

4895

1.48

19.33

6.1

3.9

5.84

5.82

kpa

0.18

680

4757

(46235355) HIV 1 and 2 tests - Meaningful Use set

1503

12052

1.34

19.15

2.4

2.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

818

5949

1.44

18.89

3.9

2.8

6.39

7.99

umol/l

2.48

727

5211

(3002032) Base excess in Venous blood by calculation

678

4757

1.48

18.87

6.2

3.9

1.26

1.81

mmol/l

4.06

597

4148

(3013826) Glucose [Moles/volume] in Serum or Plasma

3282

29278

1.29

18.50

6.5

5.1

6.55

6.62

mmol/l

0.88

3134

27531

(3022145) Colonoscopy Study observation

798

5798

1.44

18.49

1.5

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2493

21494

1.29

18.36

2.2

2.1

95.67

96.53

pmol/l

0.44

1359

11679

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

293

1693

1.77

18.18

2.2

1.8

1.15

1.19

g/l

1.23

284

1606

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

450

2937

1.58

17.49

6.6

4.1

23.77

24.21

mmol/l

2.63

443

2906

(3036481) Cortisol [Moles/volume] in Serum or Plasma

706

5066

1.45

17.43

3.6

2.3

373.71

375.86

nmol/l

0.11

666

4704

(3030981) Hyaline casts [#/volume] in Urine by Automated count

582

4022

1.50

17.40

3.7

2.5

0.25

0.41

e6/l

1.91

564

3836

(3018677) aPTT in Platelet poor plasma by Coagulation assay

992

7560

1.38

17.35

2.9

2.2

29.50

29.57

0.14

971

7352

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

341

2085

1.68

17.25

1.3

246.70

227.36

miu/ml

0.42

176

995

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1897

15911

1.29

16.95

3.6

2.7

394.19

64.81

u/l

0.52

1775

14821

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2412

20856

1.27

16.84

2.1

1.9

1.31

1.37

mmol/l

2.40

2096

17821

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

5.35

16.81

6.5

6.3

65.52

55.12

ug/min

0.26

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

217

1172

1.89

16.78

1.8

1.3

279.72

262.47

u/ml

0.33

145

737

(3044640) Blood type and Crossmatch panel - Blood

1974

16693

1.28

16.38

2.7

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1502

12268

1.31

16.29

4.4

3.6

0.33

0.15

—

114

(3042936) Bacteria identified in Isolate by Culture

934

7117

1.37

16.25

2.3

2.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4816

45546

1.38

16.24

6.8

6.0

38.38

38.72

mmol/mol

2.09

4609

43039

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

678

4911

1.43

15.84

2.8

2.5

35.43

49.06

u/l

0.73

588

4141

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4911

46636

1.40

15.79

5.4

4.8

5.83

5.86

mmol/l

1.25

4644

43374

(3032080) INR in Blood by Coagulation assay

2504

21863

1.26

15.73

16.1

13.8

1.23

1.22

inr

0.14

2091

18248

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4836

45826

1.38

15.59

4.7

4.1

1.24

1.28

mmol/l

3.91

4572

42800

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

148

718

2.09

15.57

2.5

38.94

29.50

iu/ml

0.41

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1117

8810

1.33

15.44

3.6

3.2

0.77

0.76

ug/l

0.07

775

5721

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

354

2252

1.61

15.32

1.9

1.8

1.44

1.51

g/l

0.71

312

1958

(3017446) Testosterone [Moles/volume] in Serum or Plasma

616

4412

1.44

15.28

2.5

2.3

12.79

12.77

nmol/l

0.01

574

3983

(3048929) Epstein Barr virus Ab [Presence] in Serum

321

1998

1.64

15.17

1.6

1.3

—

(3026008) Bacteria identified in Urine by Culture

1729

14559

1.27

14.40

3.4

3.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1437

11852

1.28

14.10

5.0

4.5

22.73

21.80

1.43

737

5738

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1403

11542

1.29

14.04

2.2

1.8

1.13

1.18

mg/l

0.21

1058

8872

(42529406) Shigella sp [Presence] in Stool by Culture

235

1375

1.74

14.01

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

415

2794

1.52

14.00

9.7

10.7

15.93

16.08

0.47

403

2693

(3009214) Lutropin [Units/volume] in Serum or Plasma

295

1842

1.63

13.78

1.4

10.96

9.75

u/l

0.72

237

1494

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

264

1603

1.68

13.75

3.4

2.6

192.79

185.86

0.55

251

1526

(3014111) Lactate [Moles/volume] in Serum or Plasma

607

4427

1.42

13.57

8.5

8.0

1.25

1.32

mmol/l

1.02

599

4338

(3024354) Oxygen [Partial pressure] in Venous blood

566

4085

1.43

13.41

4.6

3.3

4.86

4.59

kpa

2.21

548

3959

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

248

1496

1.69

13.25

3.6

3.4

0.32

0.34

iu/ml

0.32

136

808

(3048689) Calprotectin [Mass/mass] in Stool

923

7229

1.33

13.18

2.8

2.5

120.11

126.24

ug/g

0.19

744

5797

(3002173) Hemoglobin [Mass/volume] in Arterial blood

632

4671

1.40

13.07

8.6

9.1

120.07

122.08

g/l

1.64

617

4566

(3014765) Yersinia sp identified in Stool by Organism specific culture

229

1368

1.70

12.69

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

228

1361

1.70

12.67

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

4.50

12.57

3.5

3.1

46.78

24.11

mg/l

—

(3019977) pH of Arterial blood

734

5597

1.36

12.49

7.9

8.3

7.42

0.93

374

3080

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

494

3532

1.44

12.31

1.6

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.48

12.11

13.0

11.3

5.97

5.99

mmol/l

0.01

(3003396) Base excess in Arterial blood by calculation

727

5561

1.35

12.11

7.9

8.2

0.63

0.84

mmol/l

0.65

608

4540

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1571

13300

1.25

12.04

3.4

3.2

1341.21

1263.79

ng/l

0.28

1373

11382

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

731

5605

1.35

11.98

8.0

8.2

5.05

5.08

kpa

0.41

708

5402

(3027801) Oxygen [Partial pressure] in Arterial blood

731

5605

1.35

11.98

7.9

8.2

12.95

12.57

kpa

1.19

707

5399

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

418

2.25

11.95

1.3

1.2

69.11

82.32

—

(3024471) HLA-A [Type]

150

3.15

11.89

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

467

3328

1.44

11.84

9.5

8.4

24.30

24.78

mmol/l

2.30

467

3312

(3024932) HLA-DR beta [Type]

147

3.15

11.62

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1108

9034

1.28

11.60

1.6

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

560

4141

1.39

11.50

3.1

2.9

10.54

10.55

g/l

0.01

532

3839

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1722

14792

1.24

11.44

6.3

5.5

2.86

2.77

ug/l

0.07

1571

13414

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

271

1736

1.59

11.43

2.9

2.3

94.29

93.57

0.19

258

1677

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

545

4021

1.39

11.34

3.5

2.6

61.48

69.22

ml/min/173m2

3.87

255

1685

(3020630) Protein [Mass/volume] in Serum or Plasma

535

3938

1.40

11.29

3.1

2.7

66.17

66.56

g/l

0.66

504

3652

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

482

3501

1.41

10.99

4.0

3.5

4.43

4.51

pmol/l

1.05

454

3166

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

727

5640

1.33

10.96

1.9

1.8

—

(3016502) Oxygen saturation in Arterial blood

654

4998

1.35

10.91

8.3

8.5

96.45

95.76

2.28

631

4830

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1581

13515

1.24

10.88

2.6

2.3

2.58

2.74

mg/l

1.95

1408

11771

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

762

5972

1.32

10.69

1.9

1.8

—

(40768793) Breast Pathology biopsy report

194

1163

1.69

10.67

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

451

3257

1.42

10.62

1.5

1.4

24.20

25.86

iu/l

0.53

390

2775

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

201

1219

1.67

10.59

1.4

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

471

3432

1.41

10.54

1.3

55.53

53.87

au/ml

0.04

222

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

11.21

10.53

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

151

850

1.80

10.37

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

420

3012

1.43

10.29

4.4

3.2

127.28

130.15

g/l

1.84

408

2916

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

501

3705

1.39

10.27

2.4

25.58

20.25

au/ml

0.75

434

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

232

1471

1.60

10.25

1.2

5.40

4.24

1.08

221

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

287

1911

1.53

10.23

2.4

3.64

3.71

g/l

0.21

272

1774

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

287

1914

1.53

10.16

2.4

7.04

7.35

g/l

2.57

271

1775

(3036489) Thrombin time

303

2045

1.51

10.14

2.8

2.1

20.90

20.93

0.04

269

1787

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1630

1.56

10.02

2.3

2.4

9.83

10.26

g/l

0.98

234

1479

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

1914

1.52

9.97

2.4

4.10

4.21

g/l

1.84

271

1776

(3027945) Reticulocytes/Erythrocytes in Blood

711

5571

1.32

9.96

3.6

2.7

1.67

1.78

3.23

645

4985

(3025941) Bacteria identified in Stool by Culture

406

2914

1.42

9.90

1.3

1.2

—

(3023368) Bacteria identified in Blood by Culture

1544

13277

1.22

9.86

4.8

4.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

256

1677

1.55

9.84

3.4

3.7

311.61

3272.91

u/ml

1.09

216

1448

(40768797) Stomach Pathology biopsy report

873

7041

1.28

9.82

1.3

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

404

2908

1.42

9.70

9.8

10.2

24.16

24.20

mmol/l

0.09

396

2861

(3024928) Oxygen saturation in Venous blood

205

1284

1.62

9.55

4.3

3.1

65.86

62.00

1.62

193

1247

(3021960) Folate [Moles/volume] in Serum or Plasma

1591

13775

1.22

9.41

1.7

21.37

20.10

nmol/l

2.01

1391

11879

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1473

12662

1.22

9.35

2.7

2.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

249

1646

1.54

9.21

2.4

1.8

0.23

g/l

0.54

240

1560

(3005322) IgE [Units/volume] in Serum or Plasma

489

3674

1.36

9.09

1.4

1.3

151.17

238.30

u/ml

1.24

467

3420

(40768795) Lymph node Pathology biopsy report

474

2.00

9.08

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

286

1953

1.49

9.07

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2291

20587

1.19

8.94

4.6

3.6

1.13

0.05

estimate

0.62

560

4741

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

252

1687

1.52

8.80

3.4

2.6

3.58

3.57

g/l

0.02

238

1603

(3007164) IgA [Mass/volume] in Serum or Plasma

1311

11212

1.22

8.66

1.7

1.5

2.29

2.34

g/l

0.38

848

7162

(3003327) Ova and parasites identified in Stool by Light microscopy

289

1997

1.47

8.65

1.6

1.7

—

(3021440) Promyelocytes/Leukocytes in Blood

569

4411

1.32

8.57

5.9

4.7

0.10

0.11

0.07

163

1163

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

260

2.32

8.51

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

606

4746

1.31

8.48

4.0

4.3

5.93

29.98

ug/l

2.56

466

3798

(1761482) Bacteria [#/volume] in Urine by Culture

165

1012

1.65

8.40

4.9

4.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

435

3249

1.37

8.40

2.3

2.0

1.25

1.34

g/l

0.59

416

3013

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

217

1423

1.55

8.35

2.4

0.04

0.02

g/l

0.44

201

1290

(3017181) Myelocytes/Leukocytes in Blood

588

4597

1.31

8.33

5.9

4.6

0.88

0.90

0.07

182

1347

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

251

1700

1.50

8.31

1.4

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1703

15011

1.19

8.06

4.1

3.2

0.17

0.10

estimate

0.27

556

4562

(3002179) Metamyelocytes/Leukocytes in Blood

562

4388

1.31

8.04

5.3

4.4

0.59

0.69

0.58

169

1284

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

199

2.48

8.04

1.2

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

253

1731

1.48

7.99

3.0

2.3

441.10

642.43

ug/l

0.61

236

1636

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1474

12836

1.20

7.96

1.4

1.3

1.09

1.79

u/ml

2.73

412

3603

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

1799

1.47

7.94

2.4

2.76

2.91

g/l

2.03

246

1662

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

304

2.15

7.72

3.2

2.7

38.55

42.06

0.69

163

(3019230) Fractional oxyhemoglobin in Venous blood

172

1093

1.59

7.63

4.2

2.8

65.10

62.00

1.05

172

1087

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

271

1905

1.44

7.46

1.6

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

193

1271

1.54

7.34

2.5

2.4

0.00

g/l

-0.00

185

1206

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

313

2.09

7.20

9.3

7.1

6.42

129.22

ug/l

1.07

203

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

267

2.18

7.20

3.3

1.8

127.32

146.98

1.29

256

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3730

35227

1.17

7.19

3.7

3.3

41.02

45.08

u/l

3.02

3561

33427

(3009508) Creatinine [Moles/volume] in Urine

1901

17066

1.17

7.02

4.4

3.5

7.52

7.78

mmol/l

1.66

1690

14612

(3052851) Hemolysis interference index of Serum or Plasma

200

1342

1.51

6.99

3.2

3.1

2.21

1.94

index

0.30

106

696

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

162

1038

1.58

6.97

1.7

1.5

—

(3003694) ABO and Rh group [Type] in Blood

1778

15885

1.17

6.96

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

114

670

1.72

6.89

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

114

670

1.72

6.89

1.7

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

114

670

1.72

6.89

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

114

670

1.72

6.89

1.7

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

238

1662

1.45

6.82

2.8

2.5

0.59

0.92

g/l

0.95

212

1451

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

8.25

6.81

2.7

5.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

601

4836

1.27

6.81

3.1

3.3

—

(3023520) Reticulocytes [#/volume] in Blood

533

4225

1.29

6.81

3.3

2.7

67.64

70.39

e9/l

1.04

365

3078

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

957

8105

1.22

6.80

2.0

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

460

3579

1.31

6.76

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1274

11091

1.19

6.75

1.7

1.6

—

(3025130) Human papilloma virus identified in Specimen

148

937

1.60

6.71

2.0

1.9

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.79

6.60

4.5

3.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

201

1367

1.49

6.60

2.4

0.00

g/l

-0.00

185

1207

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

152

977

1.57

6.48

1.3

1.4

3.09

4.07

ug/l

1.20

132

894

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

606

4926

1.26

6.30

2.4

2.1

—

(3025159) Blasts/Leukocytes in Blood

558

4493

1.27

6.29

6.2

4.8

0.06

0.24

1.02

147

1116

(3037522) Nuclear Ab [Titer] in Serum

897

7606

1.21

6.27

1.4

430.28

528.19

titre

0.97

177

1612

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

107

642

1.68

6.04

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

324

2437

1.35

6.04

1.8

1.7

316.50

294.60

mu/l

0.34

306

2198

(3020682) Albumin/Creatinine [Ratio] in Urine

1739

15654

1.16

5.99

5.4

4.3

11.25

9.39

mg/mmol

0.70

1170

9905

(3012516) Albumin [Mass/volume] in Urine

1715

15425

1.16

5.97

4.6

3.6

61.72

51.84

mg/l

0.83

1158

9958

(40768441) Liver Pathology biopsy report

373

1.89

5.90

1.6

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1656

14866

1.16

5.90

5.0

3.9

0.01

0.00

estimate

0.52

627

5314

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

589

4811

1.25

5.87

2.7

2.3

0.22

0.21

g/l

3.82

565

4514

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

315

2372

1.35

5.84

2.5

2.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.78

5.82

4.3

2.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

287

2135

1.36

5.76

4.8

5.3

1.61

1.64

0.13

274

2015

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

188

1299

1.46

5.75

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

442

3500

1.29

5.71

3.7

3.0

165.20

180.38

ng/l

0.49

407

3180

(3004809) Band form neutrophils/Leukocytes in Blood

125

794

1.59

5.66

3.5

1.14

1.51

0.81

110

717

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

504

1.74

5.61

7.8

5.3

97.67

58.38

u/ml

0.26

159

(3026389) Candida sp identified in Specimen by Organism specific culture

119

751

1.60

5.54

1.3

—

(3019150) Specific gravity of Urine by Refractometry

1357

12049

1.17

5.52

4.7

3.9

1.02

1.27

kg/l

0.81

914

8035

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

503

4071

1.26

5.44

2.3

2.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

198

2.18

5.42

3.5

1.9

139.63

170.43

1.51

187

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

244

1789

1.38

5.38

1.7

1.5

14.21

5.02

iu/ml

0.27

315

(3011985) Renin [Units/volume] in Plasma

117

742

1.59

5.35

1.5

30.68

67.51

mu/l

2.65

103

668

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

109

681

1.61

5.31

6.1

6.6

11.37

11.85

mg/l

0.45

102

643

(3035933) Granulocytes/Leukocytes in Blood

169

1164

1.47

5.29

3.8

3.3

56.09

58.02

1.16

169

1164

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

200

1423

1.42

5.26

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

263

1960

1.36

5.25

4.9

5.6

0.90

0.88

0.31

252

1847

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

404

1.79

5.20

2.1

2.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

135

891

1.53

5.20

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

151

1022

1.49

5.16

1.9

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

211

1522

1.40

5.14

3.6

3.8

36.87

61.07

mg/l

1.45

179

1300

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

399

1.79

5.11

2.0

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

267

2004

1.35

5.10

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

211

1525

1.40

5.09

3.6

3.8

65.17

53.00

mg/l

0.53

178

1301

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

474

1.72

5.08

1.2

71.81

60.60

u/l

0.31

424

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

467

1.72

5.06

3.6

3.8

—

(3049717) Cytology report of Urine Cyto stain

237

1748

1.37

5.06

2.5

2.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

108

683

1.59

5.03

1.4

345.13

315.73

pmol/l

0.52

582

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.01

5.02

10.0

6.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

122

794

1.55

5.02

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.97

4.97

2.9

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

204

1472

1.40

4.97

1.2

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

274

1.94

4.95

1.2

33.81

22.95

u/l

0.51

230

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

181

2.16

4.86

2.7

2.1

350.00

21235.25

u/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

188

1350

1.41

4.73

3.8

3.6

7.61

2.75

ratio

0.69

772

(3001964) Herpes simplex virus Ag [Presence] in Specimen

145

2.28

4.69

2.0

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

224

2.02

4.69

7.3

5.3

237.49

62.91

mg/l

0.50

159

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

144

989

1.47

4.62

1.1

20.47

16.31

au/ml

0.27

258

(3027273) Bicarbonate [Moles/volume] in Venous blood

273

2088

1.32

4.62

5.3

3.4

24.78

25.26

mmol/l

1.70

262

2005

(3020876) Protein [Mass/time] in 24 hour Urine

596

1.60

4.60

3.2

2.5

1.45

1.44

g/24h

0.01

357

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

472

5720

0.81

4.59

5.1

4.7

33.27

32.19

1.45

339

3952

(3034274) Bile acid [Moles/volume] in Serum --fasting

134

910

1.48

4.55

2.6

2.2

6.53

6.08

umol/l

0.15

107

658

(3010838) Calcium [Moles/time] in 24 hour Urine

132

894

1.49

4.55

1.7

1.9

4.93

5.02

mmol/24h

0.12

119

803

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

544

1.63

4.53

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

101

646

1.57

4.52

1.7

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

430

1.71

4.51

3.8

3.3

15.85

13.30

index

0.76

269

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

187

1354

1.39

4.51

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

213

1576

1.37

4.50

2.8

2.7

—

(3011412) CD3 cells [#/volume] in Blood

510

1.64

4.39

2.0

2.4

1217.81

1238.39

e6/l

0.07

435

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

604

1.58

4.38

1.1

—

2.79

—

(21494890) Protein electrophoresis panel - 24 hour Urine

465

1.66

4.36

1.9

2.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

287

1.85

4.35

1.2

98.84

86.90

u/l

0.34

245

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

360

1.76

4.35

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

342

2719

1.27

4.34

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

413

1.70

4.32

1.2

275.00

53.33

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

413

1.70

4.32

1.2

338.00

191.15

titre

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

118

793

1.50

4.25

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

150

1057

1.43

4.24

1.4

1.5

0.50

0.43

nmol/l

0.33

117

826

(3037692) Legionella sp identified in Specimen by Organism specific culture

166

2.12

4.18

2.2

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

459

1.64

4.06

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.62

4.05

3.5

4.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

175

2.06

4.04

3.0

2.1

51.78

53.83

ug/l

0.09

170

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

318

1.77

3.98

1.1

1566.25

1499.65

miu/ml

0.17

318

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

144

2.16

3.91

1.8

1.5

8.71

8.49

ug/l

0.13

144

(3045788) Cell count panel - Pleural fluid

433

1.65

3.91

1.5

1.4

—

(3045142) Bone marrow Pathology biopsy report

558

1.57

3.90

1.2

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

271

2123

1.29

3.90

1.9

1.6

7.35

15.96

iu/ml

1.34

(4034850) Laboratory test

102

1505

0.67

3.90

11.8

9.2

—

(3047181) Lactate [Moles/volume] in Blood

195

1460

1.35

3.87

5.0

6.2

1.14

1.31

mmol/l

2.55

167

1289

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

135

951

1.43

3.86

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

135

951

1.43

3.86

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

221

1.91

3.81

1.1

133.63

354.19

ng/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

237

1830

1.31

3.81

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

199

1499

1.34

3.80

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.59

3.74

2.3

3.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

470

1.60

3.73

1.2

1.1

46.49

39.41

mg/l

0.66

399

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

203

1539

1.33

3.72

2.0

2.1

3.52

7.35

iu/l

0.56

671

(3004775) Volume in Urine collected for unspecified duration

355

1.70

3.72

3.1

2.3

759.90

623.56

1.57

236

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

456

3811

1.21

3.72

6.5

3.9

1.23

mmol/l

0.10

399

3313

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

175

2.01

3.67

1.1

1.3

90.12

90.53

0.02

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

182

1.98

3.67

1.1

85.53

91.15

0.52

(3045414) Leukocytes [Presence] in Urine

571

4881

1.19

3.65

2.3

2.1

0.00

0.01

estimate

1.79

138

1075

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

544

1.55

3.64

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

521

1.56

3.62

1.5

1.4

1168.31

3812.26

e6/l

0.90

363

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

358

1.68

3.62

2.0

2.5

540.40

525.20

e6/l

0.08

277

(3000330) Specific gravity of Urine by Test strip

296

2370

1.26

3.60

4.5

3.2

1.02

ratio

0.23

268

2119

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

183

1374

1.34

3.59

1.9

2.1

11.05

11.29

mg/l

0.17

173

1288

(1617658) Protocol used for examination of sentinel lymph nodes

347

1.68

3.47

1.0

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

188

1425

1.33

3.47

1.3

1.4

558.45

531.56

mg/l

0.26

176

1357

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

207

1.89

3.47

1.2

1.1

—

(3016750) Collection duration of Urine

265

1.78

3.46

3.4

2.2

502.93

494.06

min

0.27

194

(3019832) Treponema pallidum Ab [Presence] in Serum

808

7133

1.15

3.46

2.1

1.8

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

457

1.58

3.42

1.1

284.40

258.82

mg/l

0.51

404

(4027681) Cerebrospinal fluid IgG ratio and IgG index

349

1.67

3.41

1.4

1.2

0.63

0.60

ratio

0.22

213

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

474

4016

1.20

3.36

1.3

1.2

132.79

149.41

u/ml

0.40

167

1510

(3047189) Immunofixation for 24 hour Urine

224

1.84

3.35

2.0

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

588

1.50

3.34

1.5

33.90

32.85

g/l

0.30

531

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.35

3.30

5.4

4.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

109

762

1.44

3.30

1.1

2.19

2.92

0.37

148

(3000570) Elastase.pancreatic [Mass/mass] in Stool

194

1492

1.31

3.26

1.4

295.07

281.71

ug/g

0.36

118

855

(3028626) Oxygen [Partial pressure] in Capillary blood

168

1268

1.33

3.22

5.7

3.6

8.90

8.30

kpa

4.34

163

1241

(3037121) Protein [Mass/volume] in Urine

214

1672

1.29

3.20

5.4

3.2

313.36

366.10

mg/l

0.43

137

749

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1925

17997

1.11

3.15

3.7

3.6

76.59

84.35

ng/l

0.07

1246

11708

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.54

3.12

1.2

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

180

1380

1.31

3.11

1.8

1.4

6.90

13.94

iu/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

549

1.50

3.11

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

238

1.77

3.08

3.4

2.3

26.08

22.00

umol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

424

1.56

3.02

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

168

1282

1.32

3.01

1.7

1.9

201.73

201.53

pmol/l

0.01

158

1212

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

363

1.60

2.97

2.2

2.7

202.67

223.01

e6/l

0.42

296

(3041806) Other cells [#/volume] in Blood by Manual count

227

1.77

2.94

1.4

1.6

0.49

0.50

e9/l

0.10

227

(3039162) Centromere protein B Ab [Units/volume] in Serum

673

1.43

2.91

1.2

1.3

65.10

50.97

u/ml

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.70

2.88

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

124

911

1.37

2.87

1.4

21.88

25.31

u/l

0.63

112

757

(3008152) Bicarbonate [Moles/volume] in Arterial blood

350

2931

1.21

2.86

6.8

7.1

24.53

24.40

mmol/l

0.28

336

2805

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

437

3743

1.18

2.78

2.6

2.3

11.28

7.62

ug/l

1.03

399

3346

(3039000) Anion gap in Blood by calculation

133

994

1.35

2.77

6.2

7.4

11.23

11.39

mmol/l

0.22

121

890

(3018572) Chloride [Moles/volume] in Blood

133

995

1.34

2.76

6.2

7.4

104.96

105.28

mmol/l

0.33

121

891

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

159

1221

1.31

2.76

1.3

1.4

13.97

29.05

e6/l

0.94

107

908

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

499

1.49

2.75

1.6

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

232

1.73

2.75

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

232

1.73

2.75

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

265

2168

1.23

2.74

1.3

1.57

1.03

u/ml

0.16

161

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

161

1240

1.31

2.73

1.3

1.5

712.96

4144.84

e6/l

0.58

115

983

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

356

3002

1.20

2.71

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

273

2243

1.23

2.71

1.8

2.0

38.10

39.52

u/l

0.60

244

2030

(3037756) Immunofixation for Serum or Plasma

123

914

1.35

2.68

1.8

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

342

1.58

2.67

1.1

2.73

7.71

nmol/l

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

162

1254

1.30

2.66

1.2

1.3

3.63

3.72

mmol/l

0.53

148

1184

(40768806) Pleura Pathology biopsy report

448

1.50

2.61

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

1189

1.30

2.59

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

112

825

1.36

2.59

1.2

1.1

109.47

115.05

1.11

102

751

(3009466) Valproate [Moles/volume] in Serum or Plasma

729

0.63

2.59

4.2

5.8

357.89

363.57

umol/l

0.08

643

(3047185) IgG [Mass/volume] in Urine

7.15

2.55

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

208

1.74

2.53

4.6

3.4

0.68

1.22

2.43

208

(3023420) DNA double strand Ab [Units/volume] in Serum

274

2271

1.22

2.52

2.5

1.9

10.41

6.57

iu/ml

0.77

561

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

436

3769

1.17

2.51

1.6

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

340

1.56

2.50

1.5

27.37

20.86

u/ml

—

(3023410) Appearance of Cerebral spinal fluid

568

1.43

2.50

1.3

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

677

1.40

2.50

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

1.88

2.45

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

414

1.50

2.45

1.1

16.25

16.61

u/ml

0.03

180

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.55

2.44

2.1

2.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

456

1.47

2.42

1.4

88259.26

81307.52

e6/l

0.04

261

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

340

2888

1.19

2.42

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

167

1.80

2.40

2.2

0.12

0.16

e9/l

0.60

(3017732) Neutrophils [#/volume] in Blood

737

6636

1.13

2.37

3.1

3.2

4.17

4.58

e9/l

1.83

659

5820

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

625

1.40

2.37

1.4

1.3

0.18

0.21

nmol/l

0.33

496

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.12

2.36

7.3

6.0

337.00

396.94

umol/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1076

9900

1.11

2.35

1.4

1.3

24.44

27.73

iu/ml

0.52

310

2950

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

346

1.54

2.34

2.0

1.3

5.11

5.36

umol/l

0.18

311

(3016650) Hepatitis A virus Ab [Presence] in Serum

124

945

1.32

2.32

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.22

2.30

1.1

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

245

1.64

2.30

1.2

1.4

135.79

160.50

mmol/24h

1.52

245

(3024980) IgG subclass 4 [Mass/volume] in Serum

125

957

1.31

2.28

1.6

0.60

0.76

g/l

1.45

102

748

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

338

2887

1.18

2.27

2.5

2.3

4714.57

6080.60

u/l

0.38

153

1159

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

293

1.57

2.27

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

134

1.87

2.26

1.2

14.84

11.43

pmol/l

0.34

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

100

742

1.35

2.25

1.4

1.3

0.23

0.31

nmol/l

—

(1002224) Polysomnography panel

311

2642

1.19

2.23

1.1

—

(40765096) Chromosome analysis panel by Banding

150

1.80

2.19

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

129

1.86

2.16

1.2

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.78

2.13

1.1

1.0

0.00

0.75

u/ml

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

455

1.43

2.08

3.9

4.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

447

1.44

2.07

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

157

1256

1.26

2.06

1.3

1.2

53.91

44.48

u/ml

0.25

120

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

431

1.44

2.06

3.2

2.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

113

867

1.31

2.06

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

541

1.39

2.04

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

122

948

1.29

2.03

1.1

—

(1616796) Gas panel - Central venous blood

142

1125

1.27

2.03

6.2

3.9

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

262

1.57

2.02

2.2

1.9

2.29

1.94

umol/l

1.54

238

(3005082) Progesterone [Moles/volume] in Serum or Plasma

408

1.45

2.02

1.3

1.4

30.28

36.82

nmol/l

0.83

370

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

613

6798

0.89

2.02

1.7

1.8

1.37

1.45

2.01

560

6017

(3012898) Urea [Moles/volume] in Urine

2.40

2.02

1.4

1.6

167.09

177.98

mmol/l

0.12

(21494755) Public health laboratory ask at order entry panel

480

5402

0.88

2.01

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

118

1.87

2.01

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

991

9153

1.10

2.00

1.3

12.11

10.30

u/ml

0.25

412

3665

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

185

1.68

2.00

1.1

—

(4268621) Lupus anticoagulant assay

620

1.36

1.99

2.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

180

1469

1.23

1.99

1.2

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

174

1415

1.24

1.99

1.9

1.7

—

(3010421) pH of Blood

194

1598

1.22

1.97

5.2

3.8

7.40

7.41

2.59

194

1584

(3007566) Smooth muscle Ab [Titer] in Serum

188

1544

1.23

1.96

1.4

1.3

59.44

147.53

titre

1.56

146

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

386

1.46

1.96

1.1

1.0

—

0.62

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

194

1.65

1.95

2.0

2.2

8.28

9.58

mg/l

0.60

168

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.55

1.94

8.0

7.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

990

1.28

1.94

1.6

1.5

—

(4062490) Immunoglobulin typing, IgG

589

1.36

1.94

1.3

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

127

1.81

1.93

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

412

3625

1.15

1.93

1.5

1.6

1013.29

1000.24

mu/l

0.10

345

3065

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

421

1.43

1.92

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

135

1072

1.27

1.91

3.3

2.4

144.18

100.58

ug/min

0.56

100

654

(3013512) EKG study

1697

16073

1.08

1.91

3.7

3.5

—

0.72

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

165

1.70

1.90

1.4

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

220

1.59

1.87

1.5

1.6

4256.00

3165.41

titre

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

201

2404

0.83

1.86

1.6

1.7

0.27

0.31

mg/l

0.35

1128

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

107

1.87

1.85

1.3

1.2

261.80

295.12

pmol/l

0.31

(36660697) Celiac disease serology panel - Serum

501

4482

1.13

1.83

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

175

2118

0.82

1.83

1.5

2.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

152

1.71

1.82

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

112

875

1.29

1.82

1.3

4.54

4.60

u/ml

0.02

400

(3043410) Blood group antigens tested for on Red Blood Cells

145

1.73

1.80

1.4

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

410

1.42

1.80

1.1

8.94

9.26

iu/ml

0.02

117

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

155

1261

1.24

1.80

1.3

4.99

5.60

u/ml

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.76

1.79

1.3

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.76

1.79

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

114

896

1.28

1.78

1.3

1.2

2.55

3.47

u/ml

0.49

330

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

198

1657

1.20

1.75

1.3

48.33

37.53

u/ml

0.23

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

438

1.40

1.75

1.1

1.2

119.38

109.34

pmol/l

0.97

438

(3012441) Differential panel - Pleural fluid

456

1.39

1.72

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

110

1.82

1.72

3.1

3.4

103.93

135.99

ng/l

0.31

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.67

1.72

1.1

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.72

1.71

1.3

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.13

1.71

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

508

1.36

1.71

1.2

—

(3016038) Potassium [Moles/volume] in Urine

323

1.46

1.71

1.1

1.2

28.92

35.14

mmol/l

1.02

289

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

441

1.39

1.69

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

267

1.50

1.68

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

408

1.40

1.67

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

442

1.38

1.67

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

284

1.48

1.66

1.8

1.9

1.95

1.89

u/ml

0.02

(3020911) Cortisol [Moles/time] in 24 hour Urine

188

1.60

1.65

1.2

1.5

457.17

266.88

nmol/24h

0.21

188

(40759836) Histone Ab [Presence] in Serum by Immunoblot

443

1.38

1.65

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.10

1.65

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

112

1.79

1.64

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

291

2533

1.16

1.63

1.6

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

587

5343

1.11

1.61

8.0

6.3

—

(40763590) HLA-DQ beta [Type]

3.57

1.61

1.0

—

(40760409) HLA-A [Type] by High resolution

3.57

1.61

1.0

—

(3013862) HLA-DP [Type]

3.57

1.61

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.57

1.61

1.0

—

(40760410) HLA-B [Type] by High resolution

3.57

1.61

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

188

1581

1.20

1.60

1.4

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

114

910

1.26

1.60

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

192

1618

1.19

1.60

1.4

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

151

1.66

1.59

1.2

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

206

1.56

1.59

1.8

2.2

31.03

30.31

0.08

206

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

455

1.37

1.59

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

126

1019

1.24

1.58

1.8

1.6

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

121

1.74

1.58

1.2

1.3

105.95

104.96

0.05

116

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

313

1.44

1.56

1.3

1.5

5.49

6.66

u/l

0.82

279

(3024139) IgG subclass 3 [Mass/volume] in Serum

595

1.32

1.56

1.2

1.4

0.33

0.39

g/l

1.19

436

(3028192) IgG subclass 2 [Mass/volume] in Serum

596

1.31

1.54

1.2

1.4

2.89

2.94

g/l

0.10

437

(3027135) IgG subclass 1 [Mass/volume] in Serum

596

1.31

1.54

1.2

1.4

6.20

6.67

g/l

0.85

437

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.03

1.54

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

153

1.64

1.52

1.2

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.34

1.52

2.8

5.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

146

1207

1.22

1.50

3.2

2.3

131.87

130.20

g/l

0.39

116

948

(40761536) Microorganisms panel - Urine sediment

467

4219

1.12

1.49

5.0

3.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

116

1.73

1.48

14.0

7.3

7.56

5.33

kpa

1.59

116

(3019309) Folate [Moles/volume] in Red Blood Cells

832

7737

1.09

1.47

1.7

1141.55

1159.34

nmol/l

0.21

662

5937

(3028433) Virus identified in Specimen by Culture

155

1.62

1.46

1.3

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

411

1.37

1.46

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.37

1.45

1.0

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

395

1.37

1.44

2.2

2.8

34.00

30.07

mg/l

0.21

279

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

378

1.38

1.44

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

111

898

1.24

1.42

1.4

1.6

—

1.00

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

396

1.37

1.42

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

1143

0.79

1.41

2.1

2.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

371

1.38

1.41

1.8

1.6

96.43

580.31

pmol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

492

1.32

1.40

1.7

1.3

—

titre

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

235

2041

1.16

1.39

1.7

1.6

18.04

14.60

u/ml

0.31

519

(3011288) Drugs identified in Urine by Screen method Nominal

159

1883

0.84

1.39

1.9

3.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

1.38

2.3

2.6

—

(3005033) Fetal Nuchal fold Thickness US

182

1551

1.18

1.37

1.3

1.5

1.27

1.25

0.19

131

1125

(3033099) Centromere Ab [Titer] in Serum

119

1.68

1.37

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

272

1.44

1.37

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

382

1.36

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

289

1.42

1.36

1.3

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

383

1.36

1.34

1.2

—

(3003577) Lead [Moles/volume] in Blood

0.00

1.34

0.0

1.3

—

0.13

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

359

1.37

1.31

1.4

148.07

185.61

pmol/l

0.68

359

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

192

1.51

1.31

1.4

1.2

112.41

109.03

0.34

169

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.74

1.30

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.74

1.30

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.74

1.30

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

181

1550

1.17

1.30

1.3

2.68

8.18

u/ml

2.70

228

(3019225) pH of Specimen

405

4471

0.90

1.30

6.8

4.1

7.34

7.35

0.33

308

3229

(40761539) Cells [Type] in Urine sediment by Light microscopy

121

1.66

1.30

1.4

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

143

1201

1.20

1.29

1.6

1.7

13988.11

11655.76

e6/l

0.20

106

837

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

378

0.66

1.28

1.2

3.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

220

1917

1.15

1.27

1.4

1.5

1.26

1.15

ratio

0.81

133

1168

(40757373) Influenza virus identified in Isolate

1.72

1.27

2.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

220

1920

1.15

1.25

1.4

1.5

1.23

1.20

ratio

0.15

134

1178

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

220

1920

1.15

1.25

1.4

1.5

0.95

0.94

ratio

0.07

133

1171

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

180

1548

1.17

1.24

1.3

3.37

5.55

u/ml

0.33

138

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

278

1.41

1.24

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

279

1.40

1.22

1.4

1.7

2.01

6.16

nmol/l

1.32

217

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

382

1.34

1.21

1.2

1.6

—

(4195642) Thrombophilia screening test

101

826

1.23

1.21

1.2

—

(3024263) Appearance of Synovial fluid

246

1.43

1.20

2.4

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

202

1760

1.15

1.19

4.5

3.3

23.56

24.70

mmol/l

4.53

197

1738

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

427

1.31

1.18

1.2

—

(1761868) Lipid panel - Serum or Plasma

2131

20608

1.05

1.17

3.4

2.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

196

1706

1.15

1.17

1.7

1.6

—

(3017354) Segmented neutrophils/Leukocytes in Blood

507

1.29

1.17

3.0

3.4

57.17

57.47

0.04

439

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

102

1.67

1.16

3.1

1.7

—

(4146454) Self-monitoring of blood glucose

497

0.72

1.15

3.4

2.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.05

1.15

1.1

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

119

1.60

1.11

3.3

3.4

41.68

45.66

0.27

119

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

119

1.60

1.11

6.6

6.7

9.16

8.12

0.35

119

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

242

1.41

1.11

1.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

242

1.41

1.11

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

242

1.41

1.11

1.5

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

242

1.41

1.11

1.5

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.96

1.11

1.4

1.1

1.78

1.67

iu/ml

—

(4281824) Cell count and differential, peritoneal fluid

504

0.73

1.10

1.1

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

158

1362

1.16

1.09

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.82

1.08

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

214

1890

1.14

1.06

1.3

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1060

10079

1.06

1.05

1.6

1.7

42494927.27

30914625.49

pmol/l

0.25

906

8543

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

124

0.48

1.04

1.2

40.50

68.35

ug/l

—

124

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

220

1.41

1.04

1.1

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.27

1.03

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

239

2675

0.89

1.03

1.6

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

241

2696

0.89

1.03

1.6

2.2

—

(3000034) Microalbumin [Mass/volume] in Urine

411

1.29

1.02

3.7

3.1

85.78

45.79

mg/l

0.59

306

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

2.06

1.02

6.7

10.6

71.14

125.58

e6/l

—

(3016879) Cocaine [Presence] in Urine

222

2495

0.89

1.02

1.7

2.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

341

1.32

1.02

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

780

1.21

1.02

1.1

2.29

3.43

eliau/ml

0.78

382

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

447

1.28

1.02

1.2

1.3

2.21

2.11

mmol/l

0.18

414

(3020393) Adenovirus Ag [Presence] in Stool

1.89

1.01

1.5

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.77

1.00

1.2

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

146

1262

1.16

1.00

4.4

4.2

3.91

3.89

mmol/l

0.20

146

1249

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.00

1.00

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

243

2709

0.89

0.99

1.6

2.0

—

(3028300) Cannabinoids [Presence] in Urine

244

2719

0.89

0.98

1.6

2.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

274

1.35

0.98

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

167

1460

1.15

0.98

1.1

3.62

5.59

eliau/ml

0.47

205

(3014891) Appearance of Pleural fluid

1.80

0.98

2.2

1.5

—

(3012501) Base excess in Blood by calculation

120

1024

1.18

0.97

5.6

4.2

2.26

2.48

mmol/l

0.32

671

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

181

2051

0.88

0.96

1.1

0.59

0.63

ratio

0.56

241

(3003740) Influenza virus B Ag [Presence] in Specimen

127

1090

1.17

0.96

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

230

2058

1.12

0.95

1.4

1.5

71.53

60.30

ug/l

0.90

189

1724

(37208534) Antinuclear antibody arbitrary concentration in serum

174

1.44

0.95

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

258

0.66

0.94

2.6

2.5

104.91

152.22

umol/l

0.30

143

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.89

0.94

2.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

102

1.57

0.90

1.7

2.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

153

1340

1.15

0.90

1.5

63.09

60.07

ug/l

0.37

153

1340

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

599

6374

0.93

0.89

1.8

1.9

3.40

3.48

ratio

0.80

441

4794

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

215

1927

1.12

0.88

2.0

1.9

3.17

1.99

ug/l

0.46

192

1729

(21494434) Karyotype in Bone marrow

421

1.26

0.88

1.2

—

(3003181) Sodium [Moles/volume] in Urine

840

1.18

0.88

1.3

1.4

71.58

62.69

mmol/l

1.28

676

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

170

1.41

0.85

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.56

0.84

1.5

2.8

90.87

360.45

ug/l

0.42

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

215

0.65

0.84

2.6

2.4

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.74

0.82

1.9

1.5

2.23

3.03

mg/l

—

(3000012) Reticulocyte production index

680

1.19

0.82

3.0

2.2

0.97

0.91

0.50

452

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

116

1004

1.16

0.82

1.2

1.3

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.88

0.81

1.2

101.17

96.33

u/l

—

(4198724) Urine methamphetamine measurement

272

0.70

0.81

1.9

3.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.61

0.81

1.4

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

1.70

0.80

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

112

970

1.16

0.79

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

419

1.24

0.79

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

419

1.24

0.79

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

419

1.24

0.79

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

118

1027

1.15

0.78

4.2

2.1

0.82

0.88

nmol/l

0.41

103

880

(3034092) Cytoplasmic Ig cells/cells in Blood

1.67

0.78

5.1

7.5

0.16

0.18

0.17

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

242

1.32

0.78

1.7

1.6

0.81

2.84

u/field

2.54

178

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.78

0.0

1.3

—

4346.61

—

(3002619) Bacteria identified in Specimen by Culture

131

1.45

0.78

1.4

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.77

0.0

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

562

0.80

0.77

2.1

24.84

21.83

mg/l

0.23

206

(3017704) Immunofixation for Urine

243

1.32

0.76

1.4

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

296

1.29

0.76

1.1

1.2

—

(3014271) Vancomycin [Susceptibility]

186

0.64

0.76

2.8

2.6

—

(4038314) Semen analysis, post vasectomy

1.77

0.76

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.70

0.75

1.4

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

253

1.31

0.74

12.4

6.8

50.78

11412.68

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

101

874

1.16

0.74

1.8

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

124

1090

1.14

0.73

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

108

1.48

0.73

1.8

2.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

223

2030

1.10

0.73

1.5

1.8

3.08

4.50

mg/l

1.99

153

1498

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

156

1744

0.89

0.72

6.2

3.7

24.48

24.73

mmol/l

0.73

143

1618

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.52

0.72

1.8

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.58

0.71

1.4

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

282

1.28

0.70

2.5

2.0

120.89

116.87

ng/l

0.06

282

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

177

1.36

0.70

1.5

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

177

1.36

0.70

1.5

1.9

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

256

1.29

0.70

1.3

1.1

17.20

23.14

u/l

0.47

232

(3022621) pH of Urine by Test strip

383

4095

0.93

0.69

2.5

2.6

6.09

6.10

0.11

243

2683

(40768800) Prostate Pathology biopsy report

110

964

1.14

0.69

1.3

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

178

1.35

0.68

1.5

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

258

1.28

0.66

1.2

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.79

0.66

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

162

1.36

0.66

1.5

1.3

16.64

16.70

umol/l

0.02

136

(3044927) Protein electrophoresis panel - Urine

421

1.21

0.65

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

172

1.34

0.63

1.2

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

190

1.32

0.62

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

190

1.32

0.62

1.2

1.4

—

(3004451) EKG impression Narrative

270

1.26

0.62

1.2

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

627

1.17

0.62

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

767

1.15

0.62

3.6

3.3

0.80

0.81

nmol/l

0.10

619

(3050794) Legionella sp Ab [Presence] in Serum

1.63

0.62

1.4

1.1

—

(3045424) Erythrocytes [Presence] in Urine

275

2556

1.08

0.60

2.6

2.1

0.01

0.31

estimate

0.50

829

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

173

1896

0.91

0.59

2.3

1.9

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.54

0.59

1.3

1.8

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.2

—

1.14

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

281

1.25

0.59

1.5

1.6

10.63

6.44

u/l

0.27

234

(3014599) Egg white IgE Ab [Units/volume] in Serum

363

1.21

0.58

1.1

0.34

1.77

u/ml

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

631

1.16

0.58

1.4

—

(4024509) Urine culture

251

2331

1.08

0.57

1.8

1.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

102

905

1.13

0.57

1.2

1.3

608.00

458.18

titre

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.51

0.56

1.2

1.0

1.14

0.04

u/ml

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

159

1742

0.91

0.55

2.3

1.8

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

454

4781

0.95

0.55

1.6

1.7

3.36

3.47

mmol/l

1.43

306

3218

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

524

1.17

0.54

1.3

1.5

—

(3008295) Osmolality of Serum or Plasma

552

1.16

0.54

1.5

1.4

282.15

278.87

mosm/kgh2o

0.70

430

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

114

1024

1.12

0.53

1.3

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.54

0.53

1.2

1.6

333.17

340.41

umol/24h

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1013

0.89

0.52

3.3

3.7

359.38

615.31

u/ml

0.27

936

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

638

1.15

0.52

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.52

1.3

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.43

0.52

1.0

1.1

0.32

0.03

u/ml

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

170

1.30

0.51

1.1

69.62

53.69

u/ml

0.41

165

(3001729) Color of Synovial fluid

1.46

0.50

1.2

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

352

1.19

0.50

1.1

1.2

1.07

1.05

ratio

0.40

288

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

312

0.80

0.48

1.4

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

145

1328

1.09

0.48

1.1

2.11

2.13

u/ml

0.01

706

(3036071) Salmonella sp Ab [Titer] in Serum

181

1.27

0.48

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

199

1.26

0.47

1.0

—

(3023419) Bacteria identified in Sputum by Culture

645

1.13

0.46

3.0

2.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

182

1.26

0.46

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

797

1.12

0.46

1.3

1.5

—

(3019174) dRVVT (LA screen)

1.43

0.46

1.1

1.2

—

(3048879) Bone marrow aspiration report

117

0.68

0.45

1.5

1.9

—

2.00

—

(3032057) Clostridioides difficile [Presence] in Stool

0.61

0.45

2.0

2.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

770

0.88

0.45

1.4

6.73

7.05

mmol/l

0.42

693

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.45

0.44

1.5

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

104

1.35

0.43

1.1

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

433

1.16

0.43

1.7

1.3

1.96

2.01

u/ml

0.02

241

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.61

0.43

1.2

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

698

1.12

0.42

1.3

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

158

1.27

0.41

1.2

1.1

0.17

3.05

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

332

1.18

0.41

1.2

1.1

1.17

1.12

u/l

0.10

139

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.52

0.41

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.1

—

310.56

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.47

0.40

1.6

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.33

0.40

6.5

2.5

83.14

94.63

pmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.40

1.5

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

597

1.12

0.39

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.2

—

36.52

—

(4212803) Bone marrow aspirate examination

1.39

0.38

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

224

1.21

0.38

2.8

3.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

243

1.19

0.37

1.0

1.1

90.82

93.23

0.14

192

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

600

1.12

0.37

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

829

1.10

0.37

1.5

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.30

0.37

1.2

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

125

1.28

0.36

1.2

1.0

32.93

37.10

iu/ml

0.10

125

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

860

1.09

0.35

1.2

1.3

25.99

39.29

u/l

0.88

746

(3005988) Vibrio sp identified in Specimen by Organism specific culture

602

1.11

0.35

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.40

0.35

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.40

0.35

1.2

1.0

—

(3009343) pH of Capillary blood

332

3178

1.05

0.34

5.7

3.8

7.41

0.55

278

2648

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

320

1.16

0.34

1.8

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

163

1.23

0.34

1.2

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

297

0.84

0.33

1.4

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

472

1.12

0.33

1.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

118

1096

1.08

0.33

4.3

2.9

33.03

34.92

umol/l

0.37

105

1006

(3003329) Lymphocytes/Leukocytes in Synovial fluid

435

1.13

0.32

1.3

1.5

34.18

32.49

0.10

257

(3017569) Oxygen content in Arterial blood

274

0.84

0.32

1.9

2.4

14.44

16.40

2.36

274

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

154

0.78

0.32

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

154

0.78

0.32

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

154

0.78

0.32

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

154

0.78

0.32

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

165

1555

1.06

0.31

1.9

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.32

0.30

1.0

1.1

96.00

90.57

titre

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

340

3272

1.04

0.30

5.8

3.7

5.00

5.14

kpa

2.37

329

3150

(3020191) Ethanol [Moles/volume] in Serum or Plasma

441

0.88

0.29

1.2

1.5

1.27

1.22

promille

0.08

351

(40758292) HTLV I+II Ab panel - Serum

108

0.74

0.29

1.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

200

1903

1.05

0.28

1.8

2.0

—

(4211845) Urine protein measurement

251

1.16

0.28

2.7

3.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

892

1.08

0.28

1.0

1.1

3.12

3.95

u/ml

0.25

402

(3008898) HLA-B27 [Presence]

218

2082

1.05

0.27

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

375

1.12

0.27

1.1

0.75

2.03

u/ml

0.71

121

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

187

1.18

0.26

1.0

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.19

0.26

1.3

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.26

0.26

1.3

1.2

0.09

5.42

u/ml

0.52

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

138

1304

1.06

0.26

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

278

0.86

0.26

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.68

0.26

2.2

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

286

2969

0.96

0.26

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

288

2774

1.04

0.26

5.8

3.6

1.17

1.71

mmol/l

1.60

191

2052

(3006571) Granulocytes/Leukocytes in Synovial fluid

559

1.09

0.25

1.5

1.6

52.09

57.09

0.38

346

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

330

0.88

0.25

1.0

32.15

41.47

ng/l

1.25

228

(3014133) Dog dander IgE Ab [Units/volume] in Serum

102

956

1.07

0.25

1.0

1.1

1.66

3.47

u/ml

2.38

482

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

105

1.24

0.24

1.2

1.5

—

0.83

—

(3023511) Choriogonadotropin [Units/volume] in Urine

147

1395

1.06

0.24

1.5

1.3

—

(44813793) Dust mix specific IgE antibody measurement

378

1.11

0.24

1.1

—

(3042631) Mycobacterium sp identified in Specimen

601

0.91

0.24

3.4

2.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

227

1.15

0.23

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

328

0.88

0.23

1.0

727.33

743.21

ng/l

0.05

226

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

328

0.88

0.23

1.0

249.48

311.28

ng/l

1.65

231

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

115

1.22

0.23

1.9

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.32

0.23

3.4

2.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.32

0.23

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.23

1.6

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

119

1126

1.06

0.22

1.1

0.63

1.09

u/ml

0.78

497

(3050129) First trimester maternal screen panel - Serum or Plasma

247

2382

1.04

0.22

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

144

1.18

0.22

1.1

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

71.74

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

1.93

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.20

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

123

1168

1.05

0.21

1.1

4.64

4.94

u/ml

0.10

628

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

2.13

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.2

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.20

0.0

6.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

155

1.16

0.19

1.6

1.9

22391.30

17902.26

e6/l

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

289

1.11

0.19

1.2

8.81

8.98

mm/h

0.04

289

(3015076) Soybean IgE Ab [Units/volume] in Serum

337

1.10

0.19

1.1

0.23

1.20

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

618

1.07

0.18

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

279

0.90

0.17

1.7

2.1

8.12

8.13

mmol/l

0.00

279

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

591

1.07

0.17

1.2

1.1

—

(3022313) Gas panel - Capillary blood

216

2228

0.97

0.17

6.1

3.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

246

0.89

0.16

1.9

2.5

20.23

53.43

ug/l

0.55

227

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

802

7908

1.02

0.16

2.6

2.2

—

(3004616) Nuclear Ab [Presence] in Serum

667

0.94

0.15

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

296

0.91

0.14

1.2

1.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

574

0.94

0.14

3.2

1.9

28.71

25.28

ug/l

0.18

566

(3000285) Sodium [Moles/volume] in Blood

0.79

0.14

1.0

1.1

137.57

139.49

mmol/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

223

0.90

0.14

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

115

1106

1.04

0.14

1.1

1.04

1.42

u/ml

0.57

569

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

316

0.92

0.14

1.5

1.4

5.39

5.62

mmol/l

0.56

301

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

103

1.17

0.13

1.0

1.4

1.20

1.18

mmol/l

0.54

103

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

384

1.07

0.12

1.2

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

219

1.10

0.12

3.1

3.5

7.05

8.73

mg/l

0.85

175

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

826

1.04

0.12

1.0

1.1

0.04

0.24

u/ml

3.70

263

(3045683) HLA typing for celiac disease panel - Blood or Tissue

346

1.07

0.12

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

356

1.07

0.11

1.6

2.0

1.35

1.67

u/field

0.21

199

(3028717) Thiamine [Mass/volume] in Blood

1.16

0.11

1.4

1.3

68.00

65.49

ug/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.11

0.09

3.4

2.4

1.00

0.58

u/field

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

207

0.92

0.09

1.0

17.41

10.86

u/ml

0.42

138

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

483

0.95

0.09

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.15

0.09

8.4

7.4

11.13

10.53

—

(3006270) Folate [Moles/volume] in Blood

391

0.95

0.09

1.2

1.1

388.26

382.25

nmol/l

0.06

347

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

729

7222

1.01

0.09

2.5

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

101

981

1.03

0.09

3.0

3.4

20.71

26.82

mg/l

1.25

668

(3027035) Albumin [Mass/time] in 24 hour Urine

1.07

0.08

2.2

1.3

—

640.53

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.79

0.08

2.0

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

876

0.97

0.08

1.1

13.67

13161.96

iu/ml

0.61

198

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.06

0.08

1.1

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.06

0.08

5.0

7.2

9.79

8.11

mmol/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.04

0.08

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.03

0.07

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.05

0.07

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.04

0.07

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.86

0.07

1.9

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.85

0.07

2.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

132

0.91

0.06

2.8

2.1

17.46

15.79

umol/l

0.17

132

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

236

1.06

0.06

2.1

2.0

135.71

227.29

ug/min

—

(4015189) Microbial culture of sputum

105

0.86

0.06

5.6

2.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

780

0.97

0.06

1.6

333.49

353.97

mu/l

0.22

622

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

213

0.94

0.06

6.1

4.2

—

(3044007) Cell count panel - Peritoneal fluid

158

1.08

0.06

1.5

2.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

192

0.94

0.05

1.6

39.74

40.53

g/l

0.40

192

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

445

1.03

0.05

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

444

0.97

0.04

1.3

1.4

207188.66

91516.17

e6/l

0.39

302

(3040151) Glucose [Moles/volume] in Capillary blood

575

1.03

0.04

5.5

5.2

7.05

7.10

mmol/l

0.04

488

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

101

1.09

0.04

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

331

0.97

0.03

1.2

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

141

1.06

0.03

1.1

1.4

14.00

12.81

g/l

—

107

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

250

0.96

0.03

1.5

1.2

966.67

1049.02

titre

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

211

1.04

0.03

1.7

1.9

—

(4133840) Spirometry

137

0.95

0.01

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

104

1.06

0.01

1.0

1.3

1.39

123.39

mg/l

—

(3020650) Glucose [Presence] in Urine

184

1.03

0.00

1.7

0.00

0.03

estimate

0.80

184

(3006653) Thiamine [Moles/volume] in Blood

286

0.98

0.00

1.3

129.14

132.06

nmol/l

0.16

286

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

125

1.04

0.00

1.0

1.2

—

24.00

—

(3029396) Erythrocyte agglutination [Presence] in Blood

195

0.97

0.00

2.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

116

1.03

0.00

1.2

1.3

—

(3034426) Prothrombin time (PT)

176

1.02

0.00

1.2

1.3

29.00

28.71

0.10

176

(3020491) Glucose [Moles/volume] in Blood

386

1.01

0.00

1.7

1.8

6.52

6.42

mmol/l

0.07

280

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

151

0.99

0.00

1.3

3.3

4.71

4.79

kpa

0.12

151

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

151

0.99

0.00

1.3

3.3

10.74

10.47

kpa

0.17

151

(3006442) Creatine [Moles/volume] in Serum or Plasma

331

1.00

0.00

1.8

1.5

122.45

80.77

umol/l

0.72

331

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

309

1.00

0.00

1.2

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

419

1.00

0.00

1.4

1.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

531

1.00

0.00

1.3

1.23

1.48

nmol/l

1.02

479

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.93

0.00

1.2

2.9

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

0.97

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

54.06

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.93

0.00

1.0

1.2

—

0.71

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.95

0.00

1.3

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.94

-0.00

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.88

-0.00

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

180

1.00

-0.00

1.6

2.2

54377.10

710.22

e6/l

—

131

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.00

-0.00

1.2

6.66

10.21

mg/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

110

1.00

-0.00

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

1.0

1.1

—

(44806071) Cardiolipin IgM antibody measurement

0.96

-0.00

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.94

-0.00

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1556.67

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

100

1.00

-0.00

1.6

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.02

-0.00

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_MELANOCYTIC_TRUNK and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_TRUNK	0.926 [0.8, 1.07]	0.288
Birth year	0.996 [0.99, 1.0]	0.388

During the follow-up period (1.1.1998 — 31.12.2019), 609 out of 12216 females with CD2_BENIGN_MELANOCYTIC_TRUNK died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_TRUNK	1.086 [0.94, 1.25]	0.248
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1132 out of 10088 males with CD2_BENIGN_MELANOCYTIC_TRUNK died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_MELANOCYTIC_TRUNK.

N-year risk	Females	Males
1	0.11%	0.207%
5	0.616%	1.207%
10	1.534%	3.084%
15	2.884%	5.662%
20	5.105%	9.699%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC_TRUNK – Melanocytic naevi of trunk

GWS hits: 11

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Melanocytic naevi of trunk

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints